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1. Summary 
 
DNA double-strand breaks (DSBs) are the most deleterious damage which cells can encounter. 
Unrepaired or mis-repaired DSBs can result in genomic instability and cell death. Therefore, DSBs pose 
a serious threat to genome integrity. Two main repair pathways, canonical non-homologous end-
joining (c-NHEJ) and homologous recombination (HR), are known to play a primary role in the repair 
of DSBs. Cell cycle-specific studies have revealed that c-NHEJ is active throughout the cell cycle, 
whereas, HR is active in the late-S and G2 phase where a sister chromatid is available as a template for 
repair. Molecular characterization of these pathways has discovered various key players, such as 
Ku70/80 and DNA-PKcs of c-NHEJ and Rad51, BRCA2 and Rad54 of HR.  Recent findings have made 
it evident that when c-NHEJ or HR is impaired, alternative end-joining (alt-EJ) pathway operates to 
remove the DSBs. While alt-EJ acts as a global rescuing mechanism, the removal of DSBs by alt-EJ 
comes at a cost of elevated chromosomal translocations and sequence alteration at the break ends. 
Factors implicated in alt-EJ are Mre11, CtIP, DNA ligase 1/3 and PARP1. Recently, DNA polymerase 
theta (Polθ) was shown to promote alt-EJ by annealing the micro-homologies (MHs), present internal 
to the resected break ends. Therefore, this pathway is also referred to as DNA polymerase theta-
mediated end-joining (TMEJ). 
 
Most of the knowledge about the mechanistic details and the factors involved in HR comes from the 
studies performed with yeast (S. cerevisiase). In S. cerevisiase, Rad52 was discovered as the key HR 
player whose absence results in defects in DNA repair, increased sensitivity to IR and cell death. 
Surprisingly, loss of Rad52 in vertebrate cells has no effect on DNA repair and Rad52 knock-out mice 
are fertile and viable. However, increasing evidences suggest that Rad52 is involved in HR in 
mammalian cells. Earlier work performed in the laboratory of Prof. Löbrich showed that Rad52-GFP 
foci peak in the late G2 phase and persist in the consequent M phase. A study published by Feng et al. 
(2011) showed that, in BRCA2-deficient mammalian cells, inactivation of Rad52 is synthetically lethal 
for the cells. However, the exact function of Rad52 in BRCA2-proficient as well as deficient cells is not 
yet clearly understood. 
 
In this study the function of Rad52 during DSB repair in G2 phase mammalian cells was characterized. 
In contrast to earlier speculations, in HeLa cells it was shown that Rad52 is not involved in the loading 
of Rad51 on to the resected 3'-ssDNA overhangs in G2 phase cells and, thus, cannot compensate for 
the loss of BRCA2.  A synthetically lethal relationship was observed between BRCA2 and Rad52, 
indicating an important role for Rad52 in BRCA2-depleted HeLa and 82-6 (fibroblast) cells. 
Importantly, by using HeLa-Rad52-GFP cells, it was shown for the first time that BRCA2-depleted cells 
show significantly increased amounts of Rad52-GFP foci in G2 phase cells. yH2AX foci analysis, 
however, showed that the increased numbers of Rad52-GFP foci do not imply activation of a Rad52-
dependent alternative repair pathway. Interestingly, co-depletion of BRCA2 and Rad52 rescued the 
BRCA2 repair defect. Furthermore, it was observed that the rescue of the BRCA2 repair defect was due 
to the activation of the Polθ-mediated TMEJ repair pathway, which gave rise to increased numbers of 
chromosomal fusions. These results were true for both Hela and fibroblast (82-6 & HSC-62) cells. 
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Notably, in HeLa cells, it was shown that the two resection-dependent pathways, HR & TMEJ, are 
active simultaneously in G2 phase. Nevertheless, rescue of the BRCA2-repair defect after depleting 
Rad52 was still observed in HeLa cells. 
 
In conclusion, the results suggest that due to its ss-DNA binding activity, Rad52 binds to the resected 
3'-ssDNA overhangs in BRCA2-deficient cells. This binding of Rad52 prevents TMEJ from repairing the 
resected DSB ends as repair by TMEJ can result in increased chromosomal fusions. Thus, by preventing 
the action of TMEJ pathway, Rad52 suppresses the formation of chromosomal fusions and maintains 
genomic stability in BRCA2-deficient cells. In context to cancer therapy, inactivation of Rad52 in 
BRCA2-deficient tumors can prove to be a potential therapeutic strategy. Furthermore, in this study it 
was shown that inactivation of Polθ and BRCA2 results in significantly increased numbers of 
chromosomal fusions in HeLa cells. This result is consistent with earlier published data where it was 
shown that inactivation of Polθ in BRCA2-deficient tumors increases chromosomal aberrations and 
enhances cell killing. Therefore, combined inactivation of Rad52 and Polθ might prove to be more 
potent and, thus, provide an alternative strategy to specifically kill BRCA2-deficient cancer cells. 
 
Zusammenfassung 
 
DNA-Doppelstrangbrüche (DSBs) zählen zu den schwerwiegendsten DNA Schäden, da sie die Integrität 
des Genoms gefährden. Für die Reparatur von DSBs, stehen zwei Hauptreparaturwege zur Verfügung: 
die klassiche nicht-homologe Endverknüpfung (c-NHEJ) und die homologe Rekombination (HR). 
Zellzyklus spezifische Studien haben gezeigt, dass c-NHEJ in allen Zellzyklus phasen aktive ist, 
wohingegen HR nur in der späten-S und G2 Phase aktive ist wenn ein Schwesterchromatid zur 
Verfügung steht. Es würden bereits viele Schlüsselfaktoren der beiden Reparaturwege durch 
molekulare Charakterisierung entdeckt, z.B., Ku70/80 und DNA-PKcs, die am c-NHEJ beteiligt sind 
und die HR Proteine Rad51, BRCA2 und Rad54.Neue Studien haben erwiesen, dass DSBs in c-NHEJ 
oder HR-defizienten Zellen, durch alternative Endverknüpfung (alt-EJ) reparierte werden. Jedoch ist 
Reparatur durch alt-EJ fehleranfällig, und kann zu chromosomalen Translokationen führen sowie 
Sequenzänderungen an der Bruchstelle. Die Faktoren Mre11, CtIP, DNA ligase 1/3 und PARP1 spielen 
die Hauptrolle während dem alt-EJ. Vor kurzem Zeit haben Forscher entdeckt, dass DNA polymerase-
theta (Polθ) auch im alt-EJ beteiligt ist. Polθ übernimmt hierbei die Aufgabe mikrohomologie 
Sequenzen, die in resektierten DNA Brüchen versteckt sind, zusammen zu bringen. Daher wird alt-EJ 
auch theta-vermittelte Endverknüpfung (TMEJ) genannt. 
 
Das meiste Wissen über den Mechanismus der Reparatur durch HR ist von Studien bekannt, die in 
Hefe (S. cerevisiae) durchgeführt wurden. Rad52 wurde in S. cerevisiae als HR Schlüsselfaktor 
entdeckt. Die Abwesenheit von Rad52 in S. cerevisiae führt zu Defekten in der DNA Reparatur, 
erhöhter Strahlensensitivität und zu Zelltod. Erstaunlicherweise, hat die Abwesenheit von Rad52 in 
Säugerzellen aber keinen Phänotyp gezeigt. In den letzten Jahren gab es Jedoch  mehrere Studien, die 
Hinweise geliefert haben, dass Rad52 eine Rolle bei der HR in Säugerezellen spielt. 
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Frühere Studien der Arbeitsgruppe Löbrich haben gezeigt, nach ionisierender Strahlung (IR) Rad52-
GFP Foci in der G2 Phase langsam rekrutiert werden, ein Maximum zu späten Zeitpunkten nach 
Bestrahlung erreichen und, bis in die M Phase persistieren. Eine Veroffentlichung von Feng et al. 
(2011) hat außerdem gezeigt, dass die Inaktivierung von Rad52 in BRCA2-defizienten Zellen zu einer 
synthetischen Lethalität führt. Allerdings, sind die Funktionen von Rad52 in wild type (WT) sowie in 
BRCA2-defizienten Zellen unbekannt. 
 
In dieser Arbeit wurden die Funktionen von Rad52 in Säugerzellen charakterisiert. Im Gegensatz zu 
früheren Spekulationen, konnte gezeigt werden, dass Rad52 in HeLa Zellen nicht die Funktion 
übernimmt Rad51 auf resektierte DNA aufzuladen. Im Rahmen dieser Arbeit konnte zum ersten Mal 
gezeigt werden, dass in BRCA2-deplietierten Zellen eine signifikant höhere Zahl von Rad52-GFP Foci 
in der G2 Phase sind. Durch yH2AX Foci analyse wurde verdeutlicht, dass die höhere Zahl an Rad52-
GFPFoci allerdings nicht bedeutet dass, ein Rad52-abhängiger alternativer Reparaturweg aktiv ist. 
Erstaunlicherweise wurde beobachtet, dass eine Doppeldepletion von Rad52 und BRCA2 den BRCA2-
Reparaturdefekt aufhebt. Weiterhin, es wurde beobachtet, dass  die Reparatur in Rad52 und BRCA2 
doppeldepletierten Zellen Polθ-vermitteltes TMEJ darstellt. Es konnte gezeigt werden, dass dieser 
Reparaturweg zur vermehrtern Entstehung von chromosomalen Fusionen führt. Dieser ergebnisse 
wurden in HeLa Zellen als auch in humanen Fibroblastzelllinien (82-6 hTert & HSC-62 hTert) gezeigt. 
In HeLa Zellen es wurde außerdem gezeigt, dass zwei resektions-abhängige Reparaturwege (HR & 
TMEJ) gleichzeitig in G2 aktiv sind. 
 
Abschließend konnte gezeigt werden, dass in BRCA2-defizienten Zellen Rad52 aufgrund der ss-DNA 
Bindungsaktivität resektierte DNA Brüche binden kann. Diese bindung verhindert eine Reparatur 
durch TMEJ und daher auch die Entstehung chromosomalen Fusionen. Daher wird Rad52 für die 
Erhaltung der genomischen Integrität in BRCA2-defizienten Zellen benötigt. Im Rahmen der Krebs 
therapie bietet die Inaktivierung von Rad52 daher in BRCA2-defizienten Tumorzellen einen 
vielversprechenden Therapieansatz. Weiterhin konnte in dieser Arbeit gezeigt werden, dass in HeLa 
Zellen die Abwesenheit von BRCA2 und Polθ zur Ausbildung von chromosomalen Fusionen führt. 
Dieses Ergebnis ist im Einklang mit anderen Studien, in denen gezeigt wurde, dass die Inaktivierung 
von Polθ in BRCA2-defizienten Tumorzellen zum Zelltod führt. Daher konnte die kombinierte 
Inaktivierung von Rad52 und Polθ in BRCA2-defizienten Tumorzellen sich als eine alternative Strategie 
in der Krebstherapie erweisen. 
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2. Introduction 
 
The primary objective of living organisms (single-celled to multi-cellular) is the flawless transfer of its 
genetic material to the next generation. The deoxyribonucleic acid (DNA) is the repository of genetic 
material and performs the essential task of carrying the genetic information from one generation to the 
next. To perform such an important biological task, the integrity of DNA is highly essential. 
Nevertheless, DNA is constantly exposed to various endogenous and exogenous damaging agents. In 
fact, each of the approximate 1013 cells in the human body receives tens of thousands of DNA lesions 
per day (Jackson & Bartek, 2009). There are numerous lines of evidence which link DNA damage and 
human diseases. One of the best known examples is skin cancer which can be caused by exogenously-
induced DNA damage from exposure to ultraviolet (UV) radiation present in the spectrum of sunlight. 
DNA damage caused by tobacco smoke (cigarette smoking) is another example which can lead to lung 
cancer by causing DNA damages in lung cells. Apart from exogenously-induced DNA damage, 
endogenous damaging agents, such as byproducts of the cell metabolism (free radicals), can cause 
oxidative damages to the DNA. To combat these various threats to DNA integrity, cells have evolved 
different mechanisms to detect DNA damage, signal its presence and mediate its repair. These 
mechanisms play an important role in maintaining and stabilizing the genomic integrity and also 
prevent diverse human diseases. If the damages are not repaired, or are repaired incorrectly, they can 
lead to mutations or wider-scale genome aberrations that threaten cell viability and/or result in the on-
set of life-threatening diseases, such as cancer (Jackson & Bartek, 2009). In recent years, deficiencies 
in DNA repair genes have been linked to a number of hereditary diseases, severe developmental 
problems and predisposition to cancer (Wiesmüller, Ford, & Schiestl, 2002). 
 
2.1. Ionizing radiation and its effects on biological targets 
 
Ionizing radiation (IR) has the energy to liberate an electron from the outer electron shell of an atom 
or molecule, thereby ionizing them. IR comprises all types of radiation which can cause the ionization 
of atoms or molecules and can be distinguished as particulate or electromagnetic radiation. Sub-atomic 
particles, such as electrons, neutrons, alpha and beta particles, have a mass and belong to particulate 
radiation. On the other hand, electromagnetic radiation includes X-rays and gamma rays which have 
no mass and charge and carry energy in the form of electromagnetic waves. Human beings are exposed 
to radiation due to natural or man-made sources (summarized in Table 2.1). Occupational exposure 
(nuclear power plant), medical diagnostic exposure (X-rays) and exposure due to air travel (cosmic 
rays) are some of the common sources of radiation exposure (Environmental Sciences Training Center, 
1996). 
 
Natural sources Man-made sources 
External Sources 
 Cosmic rays 
 Terrestrial radiation (radioactive material 
in rocks, such as potassium-40) 
Medical 
Occupational 
Nuclear power 
Nuclear explosions 
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Nuclear accidents 
Internal sources 
 Inhalation (Radon gas) 
 Ingestion 
 
Table 2.1: Various natural and man-made sources of exposure to IR. Modified from the Fact sheet (1996), Environmental Sciences 
Training Center, the State University of New Jersey. 
 
The effects of exposure to IR on biological matter can be exerted through two major mechanisms: 
direct effect and indirect effect. Based on the direct effect theory, IR hits the target directly, thereby 
causing ionizations and damage. DNA is the principle target in which IR can induce base damages, 
single-strand breaks (SSBs) and double-strand breaks (DSBs). Cellular membranes, organelles, 
proteins, RNA etc., are also vulnerable to the direct effects of IR. Based on the indirect effect theory, 
the effect of IR is exerted indirectly by the formation of free radicals. IR can interact with the water 
molecules (major constituent of cells) causing their radiolysis and forming free radicals (hydroxyl 
OH•). These free radicals can interact with cellular organelles, particularly DNA, and cause severe 
damages (Desouky, Ding, & Zhou, 2015). The majority of DNA damages after X-ray irradiation are due 
to the indirect effect. 
 
 
 
Figure 2.1. Direct and indirect effects of ionizing radiation on DNA. IR can hit the DNA directly and damage the sugar-phosphate 
backbone. Alternatively, IR can hit the DNA indirectly by the formation of free radicals via radiolysis of water and result in the induction 
of base damages, single-strand and/or double-strand breaks (Desouky et al., 2015). 
 
As mentioned earlier, DNA is the primary target of IR and its damage can lead to lethal cellular 
consequences. Direct or indirect (free radicals) interactions with DNA can result in the breakage of the 
sugar-phosphate backbone of DNA, thereby causing SSBs and DSBs (Figure 2.1). SSBs are known to be 
readily repaired by the cells using the opposite strand as a template, however, base pair substitutions 
and frameshift mutations can still occur. DSBs, on the other hand, are the most detrimental and lethal 
lesions produced in cells due to IR exposure. Unrepaired or mis-repaired DSBs can result in 
chromosomal aberrations, loss of genetic information, initiation of carcinogenesis and cell death. In 
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order to sense the damage, signal their presence and promote their repair, cells have developed highly 
coordinated mechanisms, such as, cell cycle checkpoints, repair pathways and apoptosis – collectively 
termed as DNA damage response (DDR) mechanisms. The proper functioning and interplay of these 
mechanisms is highly essential for cell viability, whereas, cells with defects in DDR mechanisms are 
prone to numerous hereditary diseases and predisposed to cancer (Jackson & Bartek, 2009). 
 
2.2. DNA damage response mechanisms 
 
The DNA damage response is a network of cellular pathways which are activated when a cell 
experiences DNA damage. These cellular pathways comprises of cell cycle checkpoints and DNA repair 
pathways. The DDR mechanisms work in coordination in order to prevent deleterious consequences for 
a cell (Jackson & Bartek, 2009). 
 
2.2.1. Cell cycle checkpoints 
 
Upon induction of DNA damage, particularly IR-induced DSBs, cell cycle checkpoints are activated in 
order to prevent cells from progressing in to the next cell cycle phase and to provide an appropriate 
amount of time for the cells to repair the damages. A eukaryotic cell cycle consists of four phases: 
namely G1, S, G2 and M phase. Cyclins and cyclin-dependent kinases (Cdk) control and regulate the 
traversal of cell from one phase to the other. The cell cycle checkpoints exist at G1/S and G2/M 
boundary and inhibit cells from replicating their DNA and from undergoing mitosis, respectively. The 
protein complexes CyclinD/Cdk4/6 and CyclinE/Cdk2 together regulate the S phase entry. In order to 
prevent the progression of cells in S phase, ATM-dependent phosphorylation of p53 and Mdm2 
(negative regulator of p53) occurs which leads to the stabilization and activation of p53. As a result, 
p53 transcriptionally upregulates a Cdk inhibitor - p21 - and thereby inhibits G1/S entry. Progression 
to M phase is driven by the protein complex CyclinB1/Cdk1 where dephosphorylation of Cdk1 by the 
Cdc25 phosphatases is required. In the presence of DNA damage, ATM-dependent phosphorylation of 
Cdc25 results in the cytoplasmic translocation of Cdc25. Thus, the CyclinB1/Cdk1 protein complex is 
maintained inactivated and the cells are arrested in G2 phase (Deckbar, Jeggo, & Löbrich, 2011). 
 
2.2.2. DSB repair pathways 
 
In order to recognize and repair the break sites, a plethora of genes and protein complexes are 
activated. The MRN (MRE11/RAD50/NBS1) complex binds to the DSBs and facilitates the activation 
of ATM (Vignard, Mirey, & Salles, 2013). ATM is autophosphorylated at the break site resulting in its 
own activation and, additionally, it phosphorylates its substrates in the surrounding chromatin. One of 
the numerous ATM substrates is H2AX – an H2A histone variant – which, upon phosphorylation, is 
called yH2AX. This is considered as one of the earliest DSB signaling markers (Rogakou, Pilch, Orr, 
Ivanova, & Bonner, 1998). MDC1 recruitment amplifies the H2AX phosphorylation reaction and this 
signal amplification results in the recruitment of multiple other DDR members, such as RAP-80, 53BP1, 
KAP-1 and BRCA1 (Vignard et al., 2013). Upon recognition and signaling of the break site, mammalian 
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cells can employ two major repair pathways to repair DSBs: canonical non-homologous end-joining (c-
NHEJ) and homologous recombination (HR). 
 
 
 
Figure 2.2. Schematic representation of c-NHEJ. The DSB ends are immediately bound by the Ku70/80 heterodimer which recruits 
DNA-PKcs. After minimal end processing steps, the DSB ends are ligated by LigIV, XRCC4 and XLF. Modified from Iliakis et al. 2015. 
 
c-NHEJ is an error-prone repair pathway which rejoins DSBs with little or no end processing and 
functions throughout the cell cycle (Mao, Bozzella, Seluanov, & Gorbunova, 2008). The key players of 
NHEJ are the Ku70/80 heterodimer and the DNA-dependent protein kinase catalytic subunit (DNA-
PKcs). The Ku70/80 heterodimer binds to the DSB ends and recruits other downstream factors of 
NHEJ. DNA-PKcs is  recruited to the DNA-bound Ku70/80 heterodimer generating the DNA-PK 
holoenzyme (Jette & Lees-Miller, 2015). After minimal end processing steps by Artemis, DNA ligase IV 
(LigIV), X-ray cross-complementing protein 4 (XRCC4), XRCC4-like factor (XLF; also called 
Cernunnos) and paralog of XRCC4 and XLF (PAXX) operate to ligate the DSB ends (Ochi et al., 2015). 
A schematic representation of c-NHEJ is shown in figure 2.2. It has been shown that the DSB repair 
kinetics shows a biphasic component – a fast and a slow component – and that c-NHEJ represents the 
fast component of repair (Riballo et al., 2004). 
 
2.3. Homologous recombination 
 
A model for HR was first proposed by Robin Holliday in 1964. This model introduced the concept of 
exchange of genetic material between two homologous chromosomes through the formation of a 
Holliday junction (McCarthy, 2004). The current understanding of HR is based on data obtained from 
various model organisms and emphasizes the role of HR during meiosis and mitosis (San Filippo, 
Sung, & Klein, 2008). During DSB repair, the ultimate goal of HR is to faithfully retrieve the lost 
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sequence information at the DSB site from an undamaged homologous DNA sequence. To achieve this 
goal, HR uses the undamaged sister chromatid as a template for repair, and therefore, the damaged 
DNA molecule and the sister chromatid interact directly and undergo synapsis (Figure 2.3). This 
prerequisite (usage of a sister chromatid) restricts HR to the S and G2 phase of the cell cycle (San 
Filippo et al., 2008). 
 
 
 
 
Figure 2.3. Schematic representation of HR. DSB end resection is initiated by the MRN complex along with CtIP to generate a 3’-
ssDNA overhang, which is immediately bound by RPA molecules. BRCA2-mediated loading of Rad51 on the 3’-ssDNA forms the 
Rad51 nucleoprotein filaments, required for the strand invasion in the sister chromatid and the formation of D-loop and double-Holliday 
junctions.  Following homology search and DNA repair synthesis, the HR-intermediate structures are processed by the BTR or the 
MUS81-EME1 complex to finalize HR repair events. Modified from Iliakis et al., 2015. 
 
According to the double Holliday-junction (DHJ) model, the defining steps of HR are the nucleolytic 
degradation of 5'-DSB ends (resection), strand invasion, formation of HR-intermediate structures (D-
loops, Holliday junctions), homology search, DNA repair synthesis and processing of the HR-
intermediate structures. Depending on the pathway (dissolution or resolution) used for the processing 
of the D-loops and/or DHJ, a DNA-crossover structure could be formed (Heyer, Ehmsen, & Liu, 2010). 
Due to the possibility of formation of a DNA-crossover structure, the DHJ model is also known as gene 
conversion (GC). A schematic representation of HR is shown in figure 2.3. 
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Apart from the classical DHJ model, other sub-pathways of HR have also been described: namely, 
synthesis-dependent strand annealing (SDSA) and break-induced replication (BIR). All the sub-
pathways of HR (DHJ, SDSA and BIR) share the similar principles of HR – DSB-end resection, 
formation of a D-loop and recombination-associated DNA synthesis (figure 2.4). During SDSA, after 
the strand invasion and DNA repair synthesis steps, the invading strand is displaced back to its original 
position and anneals with the second end of the DSB. As there is no formation of DHJs during SDSA, 
no DNA-crossover structures are formed (Heyer et al., 2010). BIR is involved in the repair of one-
ended DSBs which are replication-associated and form during S phase (Cells et al., 2014). Previously, 
BIR was thought to be a dedicated repair pathway for collapsed DNA replication forks. However, it 
recently became evident that BIR is also involved in DNA replication repair in prophase and in 
alternative lengthening of telomeres (Dilley et al., 2016; Minocherhomji et al., 2015). A distinct 
characteristic of BIR is the establishment of a replication fork after D-loop formation. Notably, the D-
loop moves together with the replication fork and, thus, results in conservative DNA replication 
(Donnianni& Symington, 2013). The DHJ-sub-pathway is known to be the most complex HR 
mechanism and the different steps of this pathway are explained in detail in the next paragraphs. 
 
 
 
Figure 2.4. Different sub-pathways of HR. All the sub-pathways of HR share the common steps of DSB-end resection, formation of D-
loop and recombination associated DNA synthesis. Modified from Sebesta and Krejci et al. 2016. 
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DSB-end resection 
 
DSB-end resection defines the initial step of HR, including all the sub-pathways of HR. Notably, DSB 
end resection commits the repair to HR and avoids repair by NHEJ pathway (Shibata et al., 2014). 
Thus, resection plays an important role in the repair pathway choice. The initiation of resection in 
mammalian cells is carried out by the Mre11-Rad50-Nbs1 (MRN) complex together with CtIP. The 
endonuclease activity of Mre11 creates an incision on one of the strands of the DNA approximately 300 
nucleotides away from the break site. CtIP mediates resection by physically and functionally 
interacting with the MRN complex (Sartori et al., 2007). In G2 phase, CtIP is phosphorylated by ATM 
and ATM and Rad3 related (ATR) in a damage-dependent manner and, importantly, two Cdk sites, 
S327 and T847, have been identified to regulate resection (Huertas & Jackson, 2009). Upon formation 
of an incision away from the break end, the resection occurs bi-directionally. The exonuclease activity 
of Mre11 resects the DNA in 3' - 5' direction, towards the break end. The exonucleases Exonuclease1 
(Exo1), DNA2 and Blooms syndrome helicase (BLM) carry out long range resection in 5' - 3' direction 
(away from the break end) which results in the formation of a 3' single strand DNA (3'-ssDNA) (San 
Filippo et al., 2008). The formed 3'-ssDNA is quickly covered by a single-strand binding protein called 
Replication Protein A (RPA) and is later used for the function of strand invasion and homology search 
mediated by a recombinase Rad51. A schematic representation of DSB-end resection is shown in figure 
2.5. 
 
 
Figure 2.5. Schematic representation of DSB-end resection. Initially, the MRN complex together with CtIP creates an incision internal 
to the break end. Next, the 5’-3’ activity of nucleases such as EXO1, DNA2 and BLM carry out the long range resection to create a 3’-
ssDNA. The 3’-ssDNA is covered by RPA and performs strand invasion and homology search. 
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Formation of Rad51 nucleoprotein filaments 
 
The 3'-ssDNA generated as a result of resection, acts as the binding substrate for RPA (figure 2.5). The 
ssDNA-RPA complex protects the ssDNA from being degraded by nucleases and activates the sensor 
kinase ATR (Binz, Sheehan, & Wold, 2004). ATR promotes the activity of Checkpoint kinase 1(Chk1) 
(Shiotani & Zou, 2009), which further activates tumor suppressor BRCA2 (Breast cancer type 2 
susceptibility protein) and promotes the loading of Rad51 on the resected ssDNA (Sørensen et al., 
2005). BRCA2 interacts with Rad51 through its eight BRC (Breast Cancer) repeats (San Filippo et al., 
2008) and actively mediates the loading of Rad51 on to the RPA-coated 3'-ssDNA (Heyer et al., 2010). 
However, unlike yeast Rad52, human BRCA2 cannot bind to RPA (Jensen, Carreira, & 
Kowalczykowski, 2010). Recently, a BRCA2 partner, DSS1, has been shown to mimic ssDNA and to 
reduce the binding affinity of RPA to ssDNA (Zhao et al., 2015). Thus, BRCA2 together with DSS1 
promotes the exchange of RPA-Rad51 and facilitates the loading of Rad51 on the resected 3'-ssDNA. 
 
Strand invasion, homology search & DNA repair synthesis 
 
Strand invasion and homology search are the defining steps of HR; however, they are also the least 
understood steps of the entire HR repair pathway (Renkawitz, Lademann, & Jentsch, 2014). In 
mammalian cells, Rad51 binds to DNA and promotes ATP-dependent homologous pairing and strand 
transfer reactions in vitro (Baumann, Benson, & West, 1996). Rad51 harbors two DNA-binding sites: 
the primary binding site is required and sufficient for binding to the resected ssDNA, whereas the 
secondary binding site is necessary for homology probing (Renkawitz et al., 2014). Further on, ATP 
and Mg2+-dependent structural changes in the Rad51 protein induces proper binding to the two DNA 
substrates and mediate strand invasion (Namsaraev& Berg, 1998). The homology search is facilitated 
by holding the sister chromatids in close proximity via cohesion complexes (Nasmyth & Haering, 
2009). 
 
Studies performed with the Rad51-homolog, RecA from E.coli, have revealed that a minimum of 8 
homologous base pairs are required for the initiation of strand invasion. Only upon further pairing of 
more homologous bases (500-1000 complementary bases in mammalian cells), a stabile HR-
intermediate structure – the D-loop – is formed (Renkawitz et al., 2014). Upon strand invasion and 
homology search, Rad51 nucleoprotein filaments are required to dissociate from the chromatin for the 
final steps of HR to take place. This function is known to be carried out by the motor protein Rad54. 
An important function of Rad54 during HR is to transform the synaptic complex 
(ssDNA:Rad51:dsDNA) in to heteroduplex DNA. During this process, Rad54's ATPase activity promotes 
the removal of Rad51 from dsDNA. This makes the 3'-ssDNA available to the DNA polymerases and 
subsequent repair synthesis takes place to enable completion of HR. 
 
Proliferating cell nuclear antigen (PCNA) is known to recruit DNA polymerases at the D-loop to initiate 
DNA synthesis (Li, Stith, Burgers, & Heyer, 2009a). In vitro studies performed with yeast revealed that 
DNA Polymerase δ was efficiently recruited to the D-loop by PCNA resulting in DNA repair synthesis 
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(Li, Stith, Burgers, & Heyer, 2009b). In humans, biochemical screens have identified DNA polymerase 
η (Polη) as a factor that catalyzes DNA synthesis primed at a synthetic D-loop, whereas, DNA 
polymerase δ (Polδ) failed at doing so (Mcllwraith et al., 2005). 
 
Processing of Holliday-structures 
 
The timely processing and removal of DHJs is essential for efficient DSB repair as well as for faithful 
chromosome segregation and genome stability. In mammals, two enzyme complexes: the BTR complex 
(BLM-topoisomerase IIIα-RMI1-RMI2) and the SLX-MUS complex (SLX1-SLX4-MUS81-EME1) and 
GEN1 resolvase are known to process the Holliday-junctions. Furthermore, these complexes process 
DHJs differently – dissolution by the BTR complex and resolution by the SLX-MUS complex and GEN1 
resolvase (Sarbajna, Davies, & West, 2014). A schematic representation of dissolution and resolution 
pathways is shown in figure 2.6. 
 
For dissolution, BLM together with RMI1 and RMI2 recruits and simulates the activity of 
topoisomerase IIIα on DNA. The BTR complex collectively mediates the convergent branch migration 
of DHJs and forms a hemicatenane. The formed hemicatenane structure is then dissociated by the 
activity of topoisomerase IIIα (Sarbajna & West, 2014). The dissolution reaction carried out by the BTR 
complex yields only non-crossover (NCO) products and is therefore an important pathway to avoid 
crossover formations in somatic cells.  Thus, individuals with mutations in the gene coding for BLM 
suffer from Bloom syndrome disorder and exhibit dwarfism, sunlight hypersensitivity, increased 
chromosomal instability, increased frequency of sister chromatid exchange (SCE) and predisposition to 
cancer (Chaganti, Schonberg, & German, 1974). 
 
The SLX-MUS complex and GEN1 comprise distinct structure-selective endonucleases. MUS81 and 
EME1 belong to the XPF endonuclease family and GEN1 is an XPG family nuclease which cleaves DHJs 
by introducing symmetrical nicks across the junction (Sarbajna& West, 2014). In contrast to GEN1, 
SLX-MUS complex cleaves the DHJs poorly as their preferred DNA substrates are nicked DHJs, 3'-flaps 
and replication fork structures (H. D. M. Wyatt, Sarbajna, Matos, & West, 2013). The SLX-MUS 
complex is presumably responsible for processing single Holliday junctions (HJs) that cannot act as the 
substrate for the BTR complex. During resolution, SLX1-SLX4 introduces a cut to generate a nicked 
DHJ which can be further processed by the MUS81-EME1. Unlike GEN1, the SLX-MUS complex cleaves 
the DHJs asymmetrically. Resolution of DHJs results in the formation of crossover products and SCEs 
and, therefore, is not the preferred pathway to process DHJs (Sarbajna& West, 2014). 
 
 Introduction  13 
 
Figure 2.6. Dissolution and resolution of DHJs. Dissolution of DHJs is carried out by the BTR complex, whereas, resolution is 
performed by the MUS81-EME1 complex. For the processing of the DHJs, dissolution is the preferred pathway as no cross-over 
products are formed. Modified from Symington and Holloman et al. 2008. 
 
2.4. DNA polymerase theta-mediated end joining 
 
During the course of evolution, eukaryotic cells have evolved various repair pathways to repair DSBs. 
Resected DSBs can be repaired by three possible repair pathways, namely HR, SSA and alt-EJ. Early 
evidence for alt-EJ came from studies with c-NHEJ deficient cells where an alternative error prone 
mechanism of end joining was identified. Efficient repair of DSBs and increased formation of 
chromosomal translocations in c-NHEJ mutants or in cells treated with c-NHEJ inhibitors collectively 
suggest that additional mechanisms of DSB repair exist (Iliakis, Murmann, & Soni, 2015). Further 
evidence for the alt-EJ repair pathway came from mice studies where it was observed that c-NHEJ 
deficient mice exhibit chromosomal translocations (Corneo et al., 2007). The use of alt-EJ, thus, has 
harmful consequences on the genome integrity because of its tendency to join DSBs present on 
different chromosomes and thereby forming chromosomal aberrations and mutational rearrangements   
(Mateos-Gomez et al., 2015). 
 
The mechanistic details of the alt-EJ repair pathway remain unclear, however, molecular 
characterization of this pathway has revealed that the XRCC1/DNA ligase III complex, PARP and 
polymerase-theta (Polθ, encoded by POLQ) are involved (Sfeir & Symington, 2015). As DSB repair by 
Polθ relies on the microhomologies (MHs) present internal to the resected break ends, where Polθ 
mediates annealing of MHs, alt-EJ is also referred to as theta-mediated end joining (TMEJ) (D. W. 
Wyatt et al., 2016). In this thesis, the term TMEJ is used throughout to represent a Polθ-dependent alt-
EJ DSB repair pathway involving MHs. Studies using mammalian cells deficient for the MRN complex, 
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Mre11 or CtIP have shown that DSB end resection is required for TMEJ. Furthermore, it was shown 
that TMEJ and HR share the initial step of DSB end resection to repair DSBs in mammalian cells 
(Truong et al., 2013). In vitro experiments indicate that Polθ promotes TMEJ by using the resected 3'-
ssDNA overhang as a primer for DNA synthesis and anneals it to the second-end of the DSB at a short 
tract of MHs (Kent, Chandramouly, McDevitt, Ozdemir, & Pomerantz, 2015). The various steps of the 
proposed mechanism for TMEJ are DSB end resection, annealing of microhomologies (MHs) removal 
of heterologous flaps, gap filling DNA synthesis and ligation. A schematic representation of TMEJ is 
shown in figure 2.7. 
 
 
Figure 2.7. Schematic representation of TMEJ. DSB-end is mediated by the MRN complex and CtIP together to reveal the micro 
homologies present within the resected ends. The flaps are cut by structure-specific nucleases followed by DNA repair synthesis 
promoted by DNA polymerase theta (Polθ). DSBs are ligated by Ligase 3. Modified from Sfeir et al. 2015. 
 
Interplay between HR and TMEJ 
 
HR and TMEJ share the initial step of resection mediated by the MRN complex and CtIP. In HR, 
however, Rad51 promotes HR by driving strand exchange reaction, whereas, PARP1 mediates TMEJ by 
recruiting repair factors (such as Polθ) to MHs flanking the break (Audebert, Salles, & Calsou, 2008). 
Recently, a competitive relationship has been demonstrated between HR and TMEJ. Ceccaldi et al. 
showed that Polθ, which functions in TMEJ, binds to Rad51 and prevents the formation of Rad51 
nucleoprotein filaments and, thus, inhibits HR (Ceccaldi, Liu, et al., 2015). Furthermore, HR-defective 
tumors were shown to be dependent on Polθ-mediated repair as knockdown of Polθ in HR-deficient 
cancer cells enhanced cell death. Moreover, it was observed that inactivation of Fancd2 (an HR gene) 
and Polq in mice resulted in embryonic lethality (Ceccaldi, Liu, et al., 2015). In context of fidelity, 
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TMEJ is considered to be a mutagenic repair pathway. Chromosomal analysis of Ku80-/- cells have 
shown that Polθ-dependent chromosome end fusions are formed at the shelterin-free telomeric regions 
(Mateos-Gomez et al., 2015). 
 
2.5. Rad52 
 
2.5.1. Characterization of the Rad52 protein 
 
Most of the knowledge about the molecular mechanisms of HR and the plethora of genes and proteins 
involved in this repair pathway comes from studies performed with yeast (Saccharomyces cerevisiae). 
A number of HR genes, such as Rad50, Rad51, Rad52, Rad54, Rad55, Rad57, Rad59, Mre11 and Xrs2, 
were identified in S. cerevisiae during a genetic screening (Game & Mortimer, 1974; Symington, 
2002). Moreover, it was shown that these genes belong to the RAD52 epistasis group. Homologues of 
the RAD52 epistasis group of genes have been identified in eukaryotes and, in some cases, in 
prokaryotes and archaea too. This indicates a high level of conservation of the RAD52 group from 
single-celled to multi-cellular organisms. Indeed, mutations in these genes lead to abnormal meiotic 
and/or mitotic recombination. However, mutations in the Rad52 gene show the most severe effect on 
HR and DNA repair in S. Cerevisiae. Rad52 mutants are most IR-sensitive among all single mutants 
and additionally exhibit defects in mating-type switching, meiosis, spore viability and homologous 
DNA integration into genome (Malone & Esposito, 1980; Schiestl, Dominska, & Petes, 1993). 
Involvement of Rad52 in all the sub-pathways of HR (DSBR/GC, SDSA, BIR) in S. Cerevisiae explains 
why mutation or depletion of Rad52 exhibits the most severe phenotype. 
 
Unlike yeast Rad52 mutants, Rad52 knock-out (Rad52-/-) mice are viable, fertile without 
abnormalities, show no DNA damage sensitivity and are not predisposed to cancer. Furthermore, 
Rad52-deficient embryonic stem cells are not hypersensitive to agents that induce either simple or 
complex DSBs (Rijkers et al., 1998; Yamaguchi-Iwai, 1998). Given the important role of Rad52 in 
yeast, it came as a surprise that Rad52-/- mice exhibit almost normal DNA repair and HR phenotype 
(Rijkers et al., 1998). Nevertheless, there is increasing evidence supporting the involvement of Rad52 
in HR in mammalian cells. Human Rad52 has been shown to interact with other HR factors such as 
RPA, XPF/ERCC1 and Rad51 (Motycka, Bessho, Post, Sung, & Tomkinson, 2004; Park, Ludwig, 
Stigger, & Lee, 1996; Shen, Cloud, David, Park, & Chen, 1996). Park et al. (1996) showed that direct 
physical contact between Rad52 and RPA is essential for HR in mammalian cells (Park et al., 1996). 
Additionally, in vitro data suggests that Rad52 catalyzes D-loop formation in superhelical DNA as well 
as mediates capturing and annealing of the second end of a resected DSB post DNA repair synthesis 
(Kumar & Gupta, 2004; McIlwraith & West, 2008). 
 
Structural studies have revealed that the Rad52 protein consists of two domains – the N terminal 
domain (NTD) and the C terminal domain (CTD) (figure 2.8). The NTD is known to be well conserved 
among eukaryotes, whereas, the CTD is poorly conserved (Adzuma, Ogawa, & Ogawa, 1984; 
Bezzubova, Schmidt, Ostermann, Heyer, & Buerstedde, 1993). Distinct functions have been defined for 
the NTD and the CTD. The NTD consists of domains for ssDNA and dsDNA-binding and a self-
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associating region which is responsible for the multimerization of Rad52 (Lloyd, Forget, & Knight, 
2002; Lloyd, McGrew, & Knight, 2005). The CTD, on the other hand, is responsible for the interaction 
with RPA and Rad51 (Park et al., 1996; Shen et al., 1996). 
Figure 2.8.The NTD and CTD domains of Rad52 protein. The NTD contains a ssDNA-binding domain and the self-associating 
domain responsible for the formation of the higher order structure (heptameric rings) of the Rad52 protein. The CTD contains the RPA 
and Rad51-interacting domains. Modified from Hanamshet et al. 2016. 
Human Rad52 consists of 418 amino acids (504 amino acids in S. cerevisiae Rad52) and eight amino 
acids (411-418) located in the CTD are responsible for the nuclear and nucleolar localization and for 
the accumulation of Rad52 at the DSB sites (Koike, Yutoku, & Koike, 2013). Electron microscopy 
studies have revealed that Rad52 forms a heptameric ring structure with a large central channel (Van 
Dyck, Hajibagheri, Stasiak, & West, 1998). The self-associating region of NTD is responsible for 
retaining the ring structure and, in the presence of ssDNA, a filamentous complex is formed by Rad52 
comprising of stacks of hepatmeric rings (Kagawa, Kurumizaka, Ikawa, Yokoyama, & Shibata, 2001). 
2.5.2. Regulation of the Rad52 protein 
Several species-specific post-translational modifications for Rad52 have been described. In S.cerevisiae, 
Rad52 is constitutively phosphorylated at serine and/or threonine residues throughout the cell cycle 
(de Mayolo et al., 2006). In S. pombe, only certain conditions, such as oxidative stress or deficiency of 
Rad51 and/or Mus81, were able to induce Rad52 phosphorylation (Bellini et al., 2012). In response to 
DNA damage, Rad52 is phosphorylated at Tyr104 by c-ABL tyrosine kinase in a DNA-PKcs and ATM-
dependent manner in mammalian cells (Kitao & Yuan, 2002). 
Additionally, post-translational modification of Rad52 by addition of small ubiquitin-like modifiers 
(SUMO) takes place in S. cerevisiae, S. pombe, and mammalian cells. Rad52 sumoylation in S. 
cerevisiae is triggered by the formation of the MRX complex and the residues involved in sumoylation 
are located at the NTD (Sacher, Pfander, Hoege, & Jentsch, 2006a). In mammalian cells (HEK293T), 
the site of sumoylation of Rad52 was mapped at the nuclear localization site at the CTD suggesting 
that sumoylation might be playing an important role in the nuclear transport of Rad52 (Saito et al., 
2010). Cells carrying sumoylation-defective Rad52 are proficient in HR. However, it has been shown 
that sumoylation stimulates the function of Rad52 by protecting it against degradation by proteasomes 
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(Sacher, Pfander, Hoege, & Jentsch, 2006b). An important tumor suppressor, PTEN, was recently 
reported to physically interact with Rad52 and regulate sumoylation of Rad52 in response to DNA 
damage (Choi, Chen, & Dai, 2013). 
2.5.3. Activities of the Rad52 protein 
In S. cerevisiae, Rad52 performs the critical step of mediating the assembly of Rad51 filaments on the 
resected ssDNA, whereas, in mammalian cells, this step is carried out by BRCA2 (Feng et al., 2011). 
Rad52-mediated annealing of complementary ssDNA strands has been observed for both yeast and 
human Rad52. Most proteins involved in HR are thought to mediate the annealing of ssDNA strands, 
but the annealing activity is abolished in the presence of RPA bound to the ssDNA strands. In contrast, 
the annealing activity mediated by Rad52 takes place in the presence of RPA (Sugiyama, New, & 
Kowalczykowski, 1998). In mammalian cells, the involvement of Rad52 in SSA repair pathway has 
been attributed to its ssDNA annealing activity. By using a chromosomally integrated DSB repair 
reporter containing repeated sequences of the GFP gene, it became evident that Rad52 is involved in 
the SSA repair pathway and functions independent of Rad51 (Stark, Pierce, Oh, Pastink, & Jasin, 
2004). 
Apart from ssDNA strand annealing during SSA, a role for Rad52 to capture the second DSB end 
during HR has been proposed. In vitro studies performed with purified Rad52 have revealed that 
Rad52 is able to bind to the displaced ssDNA strand within the D-loop and anneals it to the resected 
second-end of the DSB resulting in the formation of a double Holliday-junction (McIlwraith & West, 
2008). Rad52's involvement in RNA-mediated DSB repair has also been shown recently in a study 
where Rad52-mediated annealing between complementary ssDNA and ssRNA was observed (Keskin et 
al., 2014). Furthermore, a function of inverse strand invasion between dsDNA and RNA or ssDNA has 
been described for Rad52. It was shown that Rad52 can use non-resected duplex DNA to promote 
inverse strand exchange and that RPA stimulates this activity of Rad52 (Mazina, Keskin, Hanamshet, 
Storici, & Mazin, 2017). 
2.5.4. BRCA2 and synthetically lethal relationship with Rad52 
BRCA2 is an essential tumor suppressor gene and necessary for normal cellular development. The 
importance of BRCA2 is underlined by the fact that, individuals with mutations in BRCA2 exhibit 
genomic instability and are predisposed to breast, ovarian and other cancers (Simon A. Gayther, 
Jonathan Mangion, 1997). Genetic studies have revealed that BRCA2 is one of the key DNA repair 
genes and an indispensable factor, specifically for the HR repair pathway (Rahman & Stratton, 1998). 
A direct interaction between the BRCA2 protein and Rad51 is one of the critical steps of HR, leading to 
strand exchange activity between the damaged DNA molecule and the undamaged sister chromatid 
(Baumann & West, 1998). As mentioned in section 2.3, the interaction between BRCA2 and Rad51 
takes place through the eight BRC repeats located on the C-terminal of BRCA2 (San Filippo et al., 
2008). This interaction actively mediates the loading of Rad51 on to the RPA-coated 3'-ssDNA (Heyer 
et al., 2010). Recently, a BRCA2 partner, DSS1 has been shown to mimic ssDNA to reduce the binding 
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affinity of RPA to ssDNA and thereby promote the exchange of RPA-Rad51 and facilitate the loading of 
Rad51 on the resected 3'-ssDNA (Zhao et al., 2015). 
 
In mammalian cells, no comparable function (mediating the assembly of Rad51 nucleoprotein 
filaments) has been described for Rad52. Nevertheless, in response to IR exposure, BRCA2-
independent Rad52 and Rad51 foci formation has been observed in S phase cells (Feng et al., 2011). 
Importantly, inactivation of Rad52 in BRCA2-deficient mammalian cancer cells leads to increased 
chromosomal aberrations, decreased clonogenic survival and reduced frequency of HR. Additionally, 
these effects are also observed upon inactivation of Rad52 in cells deficient for other BRCA2-associated 
proteins, such as BRCA1 and PALB2 (Lok& Powell, 2012). These observations clearly indicate that loss 
of Rad52 and BRCA2/BRCA1/PALB2 is synthetically lethal for cells. Interestingly, the Rad52 
synthetically lethal phenotype has also been seen in other organisms. For example, in chicken DT40 
cells, depletion of Rad52 is lethal with a defect in XRCC3 (a Rad51 paralog) (Fujimori et al., 2001). In 
U. maydis, loss of Rad52 demonstrates synthetic lethality with a mutant rec2 (a Rad51 paralog) (Kojic, 
Mao, Zhou, Lisby, & Holloman, 2008). It has been proposed that in case of mutant DNA repair genes, 
such as BRCA2, Rad52 might mediate an alternative repair pathway (Lok & Powell, 2012). However, 
the function of Rad52 in cells with mutant forms of BRCA2/BRCA1/PALB2 is not fully understood. 
Nevertheless, it has become evident that in the absence of key DNA repair genes, Rad52 becomes an 
essential candidate and is responsible for the survival of cells (Feng et al., 2011). 
 
2.5.5. Rad52 – a potential cancer therapeutic target 
 
Inactivation of Rad52 in healthy wild type cells has no impact on DNA repair and cell survival. On the 
other hand, as mentioned in section 2.4.4, loss of Rad52 in BRCA2-deficient cancer cells is 
synthetically lethal and boosts cell killing. This observation makes Rad52 an interesting potential 
therapeutic candidate to treat BRCA2-deficient cancers. Additionally, this approach provides an 
alternative to other strategies to kill BRCA2-deficient tumor cells, namely poly-(ADP-ribose) 
polymerase 1 (PARP1) inhibition (Lok & Powell, 2012). The search for inhibitors/chemicals which can 
potentially disrupt or inhibit the activity of Rad52 has already begun. A 13-amino acid peptide aptamer 
containing the Rad52 sequence surrounding Phe79 has been shown to prevent the binding of Rad52 to 
ssDNA by disrupting the Rad52 heptameric ring structure. Furthermore, this aptamer was shown to 
induce synthetic lethality in selective leukemia patient cells which expressed low levels of BRCA1 or 
Rad51C (Cramer-Morales et al., 2013). A virtual computer screening of drug libraries, performed by 
Sullivan et al. (2016), yielded nine small molecule inhibitors of Rad52. Out of these nine inhibitors, 
adenosine 5-monophosphate (A5MP) and 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) 
were shown to disrupt the Rad52-ssDNA binding and selectively inhibit growth of BRCA1-deficient 
HCC1937 breast carcinoma cells, BRCA1-deficient leukemia cells and BRCA2-deficient Capan1 
pancreatic adenocarcinoma cells (Sullivan et al., 2016). In another study, a high throughput screening 
assay identified 6-hydroxy-DL-dopa (6-OH-DOPA) as a small molecule Rad52 inhibitor. In mammalian 
cells, 6-OH-DOPA was shown to work by inhibiting Rad52-ssDNA binding by disrupting the Rad52 
heptameric ring structure. 6-OH-DOPA was also shown to inhibit the formation of Rad52 foci in 
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response to DNA damage by cisplatin and this inhibitor selectively killed BRCA1 and BRCA2-deficient 
human cancer cells (Chandramouly et al., 2015). 
2.6. Aim 
HR constitutes a key repair pathway dedicated to faithfully repair DNA damages. It is active mainly in 
the late S and G2 phases of the cell cycle when a sister chromatid is available as a template for repair 
(Heyer et al., 2010). The importance of HR in the maintenance of genomic integrity as well as in 
cancer avoidance is highlighted by the discovery that several human cancer-prone syndromes, such as 
Nijmegen breakage syndrome (NBS) and ataxia-telangiectasia-like disorder (A-TLD), are caused by 
defects in HR (Symington, 2002). 
In S. cerevisiae, Rad52 is the key HR factor and its absence is lethal. Biochemical analysis of S. 
Cerevisiae Rad52 has revealed that, apart from its annealing function, Rad52 interacts with Rad51 and 
performs the critical step of mediating the assembly of Rad51 nucleoprotein filaments on to the 
resected DSB ends (Sugiyama et al., 1998). In mammalian cells, the loading of Rad51 on RPA-coated 
ssDNA is performed by BRCA2. Inactivation of BRCA2 in mammalian cells confers a DSB repair defect 
in G2 phase cells and, importantly, mutations in the BRCA2 gene accounts for the majority of familial 
breast and ovarian cancers (Simon A. Gayther, Jonathan Mangion, 1997; Wooster et al., 1995). 
Inactivation of Rad52 in organisms containing BRCA2 or a BRCA2 homolog (such as U. maydis, 
chicken and mice), however, causes minimal or no HR and DNA repair defects (Kojic et al., 2008; 
Rijkers et al., 1998; Yamaguchi-Iwai, 1998). These observations suggest that, in humans, BRCA2 might 
have overtaken the function of Rad52 and that Rad52 is a dispensable HR factor. Therefore, new 
research on Rad52 declined for a long time. A recent study published by Feng et al. in 2011 evoked a 
new interest to understand the function of Rad52 in mammalian cells. This group showed that the 
absence of BRCA2 and Rad52 results in extensive chromosomal aberrations and is synthetically lethal 
for cells (Feng et al., 2011). However, the exact physiological function of Rad52 in mammalian cells is 
unclear. More importantly, the specific mechanisms underlying the Rad52 and BRCA2 synthetic lethal 
relationship are still not determined. Therefore, the aim of this study was to characterize the function 
of Rad52 in the context of DSB repair in wild type as well as in BRCA2-deficient cells. Investigating the 
function of Rad52, especially in BRCA2-deficient cells, is of particular importance because targeting 
Rad52 can prove to be a potential future strategy to treat BRCA2-mutant tumors. 
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3. Materials and Methods 
 
3.1. Materials 
 
3.1.1. Laboratory consumables 
 
Table 3.1: Laboratory Consumables 
Consumables Vendor 
Blotting Paper, 703 VWR 
Cell culture dishes (35x10 mm, 60x15 mm) nuncTM VWR 
Cell culture flasks (25 cm2, 75 cm2) TPP 
Cover slips Roth 
Centrifuge tubes (15 ml, 50 ml) Greiner 
Immersion oil Zeiss 
Kim Wipes NeoLab 
Micro tubes (eppis) Roth 
Microscope slides, superfrost Roth 
Parafilm Bemis 
Pasteur pipettes, glass Roth 
Pasteur pipettes, plastic Roth 
Pipette tips Sarstedt 
Pipette tips, filtered Roth 
PVDF membrane Thermo Scientific 
 
 
3.1.2. Instruments and Devices 
 
Table 3.2: Instruments & Devices 
Instruments & Devices Version Vendor 
Centrifuge 5415 R/5804 R Eppendorf 
Centrifuge Biofugepico Heraeus 
Cell counting chamber Neubauer Marienfeld Superior 
Chemiluminescence detection ChemiSmart 5000 VilberLourmat 
Chemiluminescence detection Fusion FX VilberLourmat 
Microscope Axiovert 200M Zeiss 
Microscope Imager.Z2 Zeiss 
Microscope (cell culture) Eclipse TS 100 Nikon 
Nanophotometer P-Class Implen 
pH Meter pMX2000 WTW 
Power Supply PowerPacTM HC BIO-RAD 
Scale TE 1502S/TE 153S-DS Sartorius 
Thermomix Comfort Eppendorf 
Ultrasound bath 1083 GFL 
Vortex Vortex genie2 Scientific Industries 
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Water bath 1083 GFL 
Western blotting system Mini Trans-blot® Cell BIO-RAD 
X-Ray tube MCN 165/796704 Philips 
 
 
3.1.3. Software 
 
Table 3.3: Software 
Software Manufacturer 
Axiovision V4.6.3.0 Zeiss Imaging Solutions 
ChemiCapt Vilber Lourmat 
FusionCaptAdvance FX7 Vilber Lourmat 
ImageJ Open Source 
Metafer MetaSystems 
 
 
3.1.4. Chemicals and Reagents 
 
Table 3.4: Chemicals & Reagents 
Chemicals & Reagents Manufacturer 
Agar Roth 
APS Roth 
Bromophenolblue Roth 
BSA AppliChem 
BrdU BD Bioscience 
DAPI Sigma-Aldrich 
DMSO Sigma-Aldrich 
EDTA Roth 
EdU Invitrogen 
Ethanol Roth 
Formaldehyde Roth 
Glycine Roth 
HCl Roth 
Isopropanol Roth 
KCl Roth 
KH2PO4 Roth 
Methanol Roth 
MgCl2 Roth 
Mounting medium Vectashield® Axxora Alexis 
Nonfat-dried milk Reformhaus 
Na2HPO4 Roth 
NaCl Roth 
NaOH Roth 
PageRuler Plus Prestained Protein Ladder Fermentas 
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PFA Roth 
PhosStop 10x Roche 
PIPES Roth 
Protease inhibitor 25x Complete Roche 
RNase A Sigma-Aldrich 
SDS Roth 
Sodiumdeoxycholate Roth 
Sucrose Roth 
TEMED Roth 
Tris Roth 
TritonX-100 Roth 
Trypsin Roth 
Tween®20 Roth 
β-Mercaptoethanol Sigma-Aldrich 
3.1.5. siRNA 
Table 3.5: siRNA 
siRNA Sequence Concentration Vendor 
Negative control 5'AATTCTCCGAACGTGTCACGT 3' 25 nM Qiagen 
BRCA2 5' TTGGAGGAATATCGTAGGTAA 3' 25 nM Qiagen 
CtIP 5' TCCACAACATAATCCTAATTT3' 50 nM Qiagen 
Rad51 5' AAGGGAATTAGTGAAGCCAAA 3' 10 nM Qiagen 
Rad52 5' CCAACGCACAACAGGAAACTT 3' 50 nM Dharmacon 
Rad54 5' GAACTCCCATCCAGAATGATT 3' 25 nM Qiagen 
PolQ 5' AAGGATCTTAGGCATTCTTAA 3' 20 nM Qiagen 
3.1.6. Transfection reagents and kits 
Table 3.6: Transfection reagents & Kits 
siRNA transfection Vendor 
HiPerFect Qiagen 
Lipofectamine®RNAiMAX Thermo Fisher Scientific 
Kits Vendor 
EdU-Click-IT Kit baseclick 
 Materials and Methods  23 
3.1.7. Inhibitors 
 
Table 3.7: Inhibitors 
Inhibitor Concentration Vendor 
Mre11 exonuclease (Mirin) 100 μM (Shibata et al., 2014) 
PARP (Olaparib) 1 nM Calbiochem 
 
 
3.1.8. Antibodies 
 
Table 3.8: Primary antibodies 
Antibody Species Dilution Order 
Number 
Vendor Application 
GAPDH Rabbit 1:1000 SC-25778 Santa Cruz WB 
GFP Mouse 1:2000 11814460001 Roche IF 
pRPA (pT21) Rabbit 1:10000 Ab109394 Abcam IF 
Rad51 Mouse 1:10000 Ab63801 Abcam IF 
yH2AX Mouse 1:2000 05-636 Merck IF 
yH2AX Rabbit 1:2000 2212-1 Epitomics IF 
 
 
Table 3.9: Secondary antibodies 
Antibody  Dilution Order Number Vendor Application 
Goat anti-mouse AlexaFluor 
488 
 1:1000 A11001 Molecular 
Probes 
IF 
Goat anti-mouse AlexaFluor 
594 
 1:1000 A11005 Molecular 
Probes 
IF 
Goat anti-rabbit AlexaFluor 
488 
 1:1000 A11008 Molecular 
Probes 
IF 
Goat anti-rabbit AlexaFluor 
594 
 1:1000 A11012 Molecular 
Probes 
IF 
Goat anti-mouse IgG-HRP  1:10000 Sc-2031 Santa Cruz WB 
Goat anti-rabbit IgG-HRP  1:30000 Sc-2030 Santa Cruz WB 
 
 
3.1.9. Solutions, buffers and media 
 
Table 3.10: Solutions, buffers and media 
Buffers   
PBS 137 mMNaCl 
2.7 mMKCl 
8 mM Na2HPO4 
1.5 mM KH4PO4 
pH 7.4 
TBS 20 mMTris/HCl pH 7.6 
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137 mMNaCl 
 
Cell culture   
Dulbeccos Modified Eagles 
Medium (DMEM) 
Sigma-Aldrich  
Minimum Essential Medium 
Eagle (MEM) 
Sigma-Aldrich  
Fetal Calf Serum (FCS) Biochrom  
Non-essential amino acids 
(NEA) 
Biochrom  
Trypsin/EDTA 0.5 M EDTA 
2.5% (v/v) Trypsin 
pH 8 
in PBS 
   
Immunofluorescence   
Fixation 2.5% Formaldehyde in PBS 
Washing 1 1% FCS in PBS 
Permeabilization 0.2% triton-100 in PBS/1%FCS 
Blocking 5% BSA in PBS/1%FCS 
Washing 2 0.1% Tween in PBS/1%FCS 
DAPI 0.4 µg/ml in PBS 
   
Western Blot   
Transfer buffer 20 mMTrisHCl 
150 mM Glycine 
pH 8.3 
Washing 0.1% Tween20 in TBS 
Blocking 5% non-fat milk 
0.1% Tween20 
in TBS 
Antibody solution 1% non-fat milk 
0.1% Tween20 
in TBS 
Lumi-Light Western Blot Roche  
WeternBright™ Quantum/Sirius Advansta  
 
 
3.1.10. Cell lines 
 
Table 3.11: Cell lines 
Cell line Charateristics & Culture method 
HeLa-S3 human cancer cell line derived from cervical cancer cells isolated from Henrietta 
Lacks in 1951, cultivated in DMEM supplemented with 10% FCS and 1% NEA and 
passaged twice a week (1:8 to 1:10) 
HeLaRad52GFP HeLa-S3 cells stably transfected with pEGFP-Rad52 (L60) plasmid, size – 5973 bp, 
Resistance to Kanamycin and G418, Dissertation, Dr. Andreas Taubmann (2015) 
82-6 hTert hTert-immortalized wt human fibroblast cell line, cultivated in MEM supplemented 
with 20% FCS and 1% NEA and passaged weekly (1:10) 
HSC-62 hTert hTert-immortalized BRCA2-deficient human fibroblast cell line, cultivated in MEM 
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supplemented with 20% FCS and 1% NEA and passaged weekly (1:10) 
 
3.2. Methods 
 
3.2.1. Cell culture 
 
All cell lines used in this study were cultivated at 37°C with 5% atmospheric CO2. For cell culture only 
sterile media, buffers and cell culture flasks were used. 
 
Thawing of cells 
 
The correct position (Tower number, box number and position in box) of the cryotube containing the 
frozen cells in the liquid nitrogen tank was searched in the cryo-databank. The cryotube was removed 
from the liquid nitrogen tank and placed in a 37°C waterbath for approximately 2-3 minutes. The cell 
suspension was mixed with 5 ml medium and centrifuged for 5 min at 4°C and 1000 rpm. After 
centrifugation, the supernatant was discarded and the cell pellet was resuspended in 5 ml of fresh 
medium and transferred to a 25 cm2 cell culture flask. After 24 h, depending on the confluency, the 
cells were transferred to a 75 cm2 cell culture flask. 
 
Cell passaging 
 
In order to passage cells, the medium was removed and the cells were washed gently twice with PBS. 2 
ml of Trypsin/EDTA was added and the cells were incubated at 37°C and 5% CO2 for approximately 5 
min to ensure complete detachment of cells from the surface of the flask. The trypsinization reaction 
was stopped by adding 8 ml of medium and the cells were resuspended. After resuspending, the cells 
were passaged at a ratio of 1:8 to 1:10 depending on the cell line and confluency. All cell lines, 
appropriate media and passaging frequencies are listed in section 3.1.10. 
 
Cell seeding 
 
For cell seeding, the cell number was determined using a Neubauer cell counting chamber. 
Appropriate numbers of cells were seeded depending on the size of the cell culture dish (Table 3.12). 
 
Table 3.12 Cell seeding 
Cell number Size of cell culture dish Medium 
3.5 x 104 24-well plate 1 ml / well 
2.5 x 105 35 mm 2.2 ml / dish 
5.0 x 105 60 mm 5.5 ml / dish 
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3.2.2. Transfections and treatment with inhibitors 
siRNA transfection 
Cells were transfected with small interfering RNA (siRNA) (see Table 3.5) either using HiPerFect or 
Lipofectamine® RNAiMAX. For transfection with HiPerFect, cells were transfected immediately after 
cell seeding, followed by a second transfection 24 h later. For the transfection solution, medium 
without serum was combined with siRNA and HiPerFect (Table 3.13). The mixture was then vortexed 
for 1 min, incubated at RT for 10 min and added dropwise to the cells under constant and slow 
rotation of the dish. Cells were incubated at 37°C with 5% atmospheric CO2for 72 h after the first 
siRNA transfection until irradiation to ensure efficient depletion of the target protein. 
Table 3.13: siRNA transfection solutions with HiPerFect 
Cell culture dish Medium without 
serum 
HiPerFect siRNA 
24 well (1 ml medium) 44.4 µl 4.44 µl 0.53 – 2.5 μl 
35 mm (2.2 ml medium) 100 µl 12 µl 1.2 – 3 μl 
60 mm (5.5 ml medium) 240 µl 28.8 µl 2.88 – 7.2 μl 
For transfection with Lipofectamine® RNAiMAX, the cells were transfected 24 h after cell seeding to 
ensure that all the cells are adherent to the surface of the flask and are 60 – 80% confluent. 
Appropriate amounts of Lipofectamine® RNAiMAX reagent with Opti-MEM® medium and siRNA with 
Opti-MEM® medium were put in two separate tubes A and B (Table 3.14). The components from tube-
B were transferred to tube-A in 1:1 ratio and vortexed for 5 seconds. The solution was incubated for 5 
min at RT and added dropwise to the cells under constant and slow rotation of the dish. Cells were 
incubated at 37°C with 5% atmospheric CO2 for 48 h after siRNA transfection until irradiation to 
ensure efficient depletion of the target protein. 
Table 3.14: siRNA transfection solutions with Lipofectamine® RNAiMAX 
Cell culture dish Tube A Tube B 
35 mm (2.2 ml medium) 4.5 µl 
Lipofectamine®RNAiMAX + 
150 µl Opti-MEM® medium 
1.5 – 2.5 µl siRNA + 150 µl Opti-
MEM® medium 
Inhibitor treatments 
The inhibitors listed in table 3.7 were added to the cell culture medium 1 h prior to irradiation and 
were maintained in the medium during the entire repair incubation time. 
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3.2.3. DNA damage induction 
Cells were irradiated with X-Rays to induce DSBs. 30 min prior to irradiation, EdU (1 µl/ml) was 
added to the cell culture medium to label S phase cells. EdU is a thymidine analogue which 
incorporates into the DNA of replicating cells and thus marks S phase cells. Using EdU treatment, all 
the cells which were in S phase at the time of irradiation and all the cells which entered S phase 
during the repair incubation time were marked. 
X-Ray irradiation 
For irradiation with X-Rays, cells were seeded on sterile glass coverslips in cell culture dishes (Section 
3.2.1.) at least 24 h prior to irradiation. Cells were irradiated using a Philips X-Ray tube equipped with 
a tungsten anode and a thin beryllium window. A 1 mm aluminum plate was used to filter soft (low 
energy) X-Rays and for holding samples. The setting of the equipment for irradiation was 19 mA and 
90 kV. Irradiation was performed under consideration of the dose doubling effect of glass slides (Kegel, 
Riballo, Kühne, Jeggo, & Löbrich, 2007). 
3.2.4. Immunofluorescence staining and microscopic analysis 
Fixation and permeabilization 
Once the repair incubation time was over, the cells were washed with PBS and fixed with 2.5% 
formaldehyde for 15 min at RT. After fixation, the cells were washed (3 times for 10 min) with PBS 
and incubated with 0.2% TritonX-100 for permeabilization. Following permeabilization, the cells were 
again washed (3 times for 10 min) with PBS/1% FCS and BSA blocking solution was added for a 
minimum of 30 min at RT. 
Staining 
Cells were incubated with appropriate primary antibodies (Table 3.8) diluted in BSA solution at 4°C 
over night. The following day, cells were washed with PBS/1%FCS/0.1% Tween (3 times for 10 min) 
and incubated with EdU-Click solution for 30 min at RT. Manufacturer's instructions were followed to 
prepare the EdU-Click solution. Next, the cells were washed again with PBS/1%FCS/0.1%Tween (3 
times for 10 min) and incubated with the appropriated secondary antibodies (Table 3.9) diluted in 
BSA solution for 60 min at RT. Cells were subsequently washed 3 times for 5 min with 
PBS/1%FCS/0.1% Tween and incubated with DAPI solution for 5 min at RT to stain cell nuclei. 
Finally, the cells were washed with PBS for 5 min and the coverslip was transferred on to a 
microscopic slide with 2 µl of mounting medium and sealed with nail polish. 
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Microscopic analysis 
IF staining was analyzed using a semi-automated microscopy approach. Metafer software was used to 
scan the cells for DAPI and EdU signal intensity which gave a horse-shoe shaped histogram depicting 
the different cell cycle phases (Figure 3.1). The cell population was gated according to the cell cycle 
phase of interest (G1, S or G2) and for each experiment and condition a minimum of 40 cells were 
analyzed. 
Figure 3.1. Identification of various cell cycle phases. HeLa cells were irradiated with 2 Gy and stained for EdU and DAPI. The cells 
were scanned using a semi-automated scanning system by Metafer software. The cell cycle phase of interest (G1, G2 or S phase) was 
gated and cell cycle specific analysis was performed. Taken from Biehs et al. 2017. 
Statistical analysis 
To obtain replicates, each experiment was repeated independently by seeding and treating cells on 
different days. For each individual experiment, cells with different passage numbers were used and all 
the solutions were freshly prepared. For all the data points with n ≥ 3, the SEM between means of the 
independent experiments was calculated. A two-sample Students test was used to calculate the P 
values (* = p<0.05, ** = p<0.01, *** = p<0.001). 
3.2.5. Western Blot 
Western Blot was used to check the depletion efficiencies of siRNA treatments. Cells were seeded in 35 
mm dishes and transfected with siRNAs as described in section 3.2.2. 
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Cell Harvest 
 
Cells were washed with ice-cold PBS and scrapped off the surface of the dish by using a scrapper and 2 
ml ice-cold PBS. The cell solution was transferred in a 15 ml falcon tube. For efficient removal of all 
remaining cells, the cell culture dish was washed with 2 ml ice-cold PBS and the cells were centrifuged 
for 3 min at 1500 rpm to form a cell pellet. This cell pellet was then transferred to the 15 ml falcon 
tube. 
 
Cell lysis 
 
Cells were resuspended in 50 – 200 μl lysis buffer (RIPA buffer + protease inhibitor + Phosphostop) 
depending on the size of the cell pellet. For complete and efficient cell lysis, the cell lysate was placed 
in an ultrasound bath (3 times for 1 min) and briefly vortexed in between. Following this, the cells 
were incubated for 30 min on ice and subsequently centrifuged at 4°C and 13000 rpm for 30 min. The 
supernatant was transferred in a fresh 1.5 ml micro tube. 
 
Bradford protein assay 
 
Protein concentration in samples was determined by Bradford protein assay. For each sample, 1 μl 
protein was added to 800 μl MilliQ. 200 μl of Bradford reagent was added to each sample, briefly 
vortexed and incubated for 5 min. Absorption was measured immediately at 590 nm using a 
Nanophotometer. 
 
Western Blot 
 
The samples were mixed with 5x loading buffer (Laemmli) and boiled for 5 min at 95°C to denature 
the proteins. Following this, the samples were loaded in gel pockets and electrophoresis buffer was 
added to the chamber. The gel was run for 10 min at 95 V for optimal accumulation of the proteins in 
the stacking gel. Once the proteins entered the running gel, the voltage was increased to 130 V. 
Consequently, the total running time varied depending on the size of the proteins. After SDS PAGE, the 
proteins were transferred (blotted) on to a PVDF membrane which was activated by incubation in 
methanol for at least 1 min. The gel and the membrane were sandwiched tightly between multiple 
layers of filter papers and sponges. Additionally, air bubbles were removed to ensure optimal transfer. 
The assembled gel holder cassette was placed inside the transfer chamber with the membrane facing 
the anode. Blotting buffer was added and an ice block was placed inside the chamber and a current of 
310 mA was applied for approximately 3 h, depending on the size of the protein of interest. After 
protein transfer, the membrane was blocked with 5% non-fat milk in TBS-T for 1 h. After blocking, the 
membrane was incubated with appropriate primary antibodies (Table 3.8) at 4°C for overnight. 
Following day, the membranes were washed (3 times for 10 min) with TBS-T and incubated with 
appropriate HRP-conjugated secondary antibodies (diluted in 1% non-fat milk, Table 3.9) for 1 h at 
RT. Finally, the membrane was washed in TBS-T (3 times for 5 min) before signal detection. An HRP 
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substrate was added to the membrane, resulting in a chemical reaction that releases luminal, which 
emits a chemiluminescent signal that was detected using ChemiSmart5000 or Fusion FX image 
acquisitions systems. 
 
3.2.6. Establishment of EdU-BrdU double-labeling 
 
The EdU-BrdU double-labeling was established to mark G2 phase cells and to analyze them in the 
consequent G1 phase. This method allowed strict analysis of those cells which were irradiated in G2 
phase and entered the consequent G1 phase during the repair incubation time. 
 
EdU-BrdU double-labeling 
 
S-phase cells were pulse-labeled with EdU by treating the cells with 1 µM EdU (1 µl/ml) and storing 
them in an incubator for 1 h. After 1 h, the cells were washed thoroughly twice with PBS, fresh 
medium was added to the cells and again stored in an incubator for 1 h. This incubation time (a total 
of 2 h) allowed the EdU-marked mid- and late-S phase cells to enter the G2 phase. Consequently, a 
small G2 phase cell population was EdU-positive. Next, 10 mM BrdU (10 µl/ml) was added to the 
medium and the cells were stored for 1 h in an incubator. Like EdU, BrdU is a thymidine analog and 
gets incorporated in to the DNA of replicating cells. BrdU was kept in the medium during the entire 
repair incubation time. As a result, the S phase cells which did not traverse in to the G2 phase during 
the first 2 h of incubation time were double-labeled with EdU-BrdU and the G1 phase cells entering S 
phase were BrdU-labeled. A flowchart of EdU-BrdU double-labeling is shown in figure 3.2. 
 
 
 
Figure 3.2. Flowchart of EdU-BrdU double-labeling protocol. The cells were pulse labeled with EdU and incubated for 2 h which 
allowed the mid- and late-S phase to traverse in to G2 phase. Later on, the cells were incubated with BrdU during the whole repair 
incubation time. This EdU-BrdU double-labeling allowed specific analysis of those cells that were irradiated in G2 phase and entered the 
consequent G1 phase during harvest. 
 
 
Irradiation, fixation and staining 
 
After double-labeling with EdU-BrdU, cells were irradiated with 2 Gy X-Rays and harvested at 8, 10 
and 12 h post irradiation. For fixation, the cells were treated with 2.5% Formaldehyde for 15 min at 
RT and then washed (3 times for 10 min) with PBS. After fixation, cells were permeabilized with 0.5% 
Triton X-100 and blocked with 5% BSA solution for 30 min at RT. Next, the cells were incubated with 
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appropriate primary antibodies (diluted with BSA solution) at 4°C overnight. Next day, the cells were 
washed with PBS/1% FCS (3 times for 10 min) and the primary antibodies were cross linked by 
treating the cells with 2.5% Formaldehyde for 20 min at RT. Afterwards, the cells were washed with 
PBS and the DNA was denatured by incubating the cells with 2.5 M HCl for 20 min at RT. Next, the 
cells were washed with PBS for a minimum of 1 h. After denaturing the DNA, the cells were incubated 
for 2 h with fluorophor-conjugated primary antibody against BrdU to stain BrdU. Following this, the 
cells were washed (3 times for 10 min) with PBS/1%FCS and EdU-Click-IT staining, secondary 
antibody incubation and DAPI staining was performed as described in section 3.2.4. Finally, the cells 
were washed with PBS for 5 min and the coverslip was transferred on to a microscopic slide with 2 µl 
of mounting medium and sealed with nail polish. 
Microscopic analysis 
EdU-BrdU double-labeling and IF staining were analyzed using a semi-automated microscopy 
approach. Metafer software was used to scan cells for EdU vs DAPI and BrdU vs DAPI signal intensity 
which gave a horse-shoe shaped histogram depicting the different cell cycle phases. The cell cycle 
distribution and the exact position of the analyzed cells can be seen in figure 4.17 and 4.18. For foci 
quantification, only the EdU-positive-BrdU-negative G2 and G1 phase cells were analyzed. For each 
experiment and condition a minimum of 40 cells were analyzed. Statistical analysis was performed as 
described in section 3.2.4. 
3.2.7. G2 phase Premature Chromosome Condensation (PCC) assay 
Drug-induced G2 phase premature chromosome condensation was performed to yield chromosomes 
with two chromatids which are readily detected by preparing chromosome spreads on a microscopic 
slide. For PCC assay, cells were seeded in 65 mm culture dishes, treated with siRNA and/or inhibitors 
(section 3.2.2.), irradiated with 2 Gy of X-Rays (section 3.2.3.) and harvested at 8 – 10 h post 
irradiation. 
Calyculin A-treatment and fixation 
30 min before harvesting, 50 ng/ml of Calyculin A (1 µl/ml) was added to the cells. Calyculin A 
induces PCC by inhibiting serine/threonine protein phosphatases 1 and 2A (PP1 and PP2A). Treatment 
of cells with Calyculin A also detaches the cells from the surface of the dishes. After Calyculin A 
treatment, the cells were collected in 15 ml falcon tubes and centrifuged (4°C/400 g/5 min). The 
supernatant was discarded and the cell pellet was resuspended in 5 ml of pre-warmed KCl (75 mM) 
and incubated in a water bath (37°C) for 20 min. After KCl-treatment, the falcon tubes were 
centrifuged (4°C/400 g/5 min) and the supernatant was discarded. The cell pellet was fixed by adding 
10 ml of ice-cold methanol-acetic acid solution (3:1) drop wise and with constant vortexing and 
incubated for 10 min at RT. The fixation step was repeated three times and the falcon tubes were 
stored at 4°C overnight. 
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Preparation of chromosome spreads 
Next day, the cell-fixative solution was centrifuged (4°C/400 g/5 min) and, depending on the size of 
the cell pellet, 200-400 μl of the fixative (supernatant) was left in the falcon tubes and the rest was 
discarded. To prepare chromosome spreads, the cell pellet was resuspended in the fixative (200-400 
μl) and approximately 20-30 μl of the cell solution was dropped on a moist microscopic slide from a 
height of 30-50 cm. The microscopic slides with the chromosome spreads were air dried and stored at 
RT until the staining step. 
Giemsa staining and microscopic analysis 
To stain the chromosome spreads, 6% of Giemsa stain was prepared with PBS. The microscopic slides 
were dipped in the Giemsa stain and incubated for 15 min at RT. After incubation with Giemsa stain, 
the slides were washed with MilliQ water to get rid of the extra stain and to ensure clean Giemsa-
stained chromosome spreads. The slides were air dried and stored at RT until microscopic analysis. 
The chromosome spreads were scanned using Metafer software. Only the G2 phase chromosome 
spreads with two chromatids were taken in to account for analysis. For each experiment and condition 
a minimum of 40 chromosome spreads were analyzed. Statistical analysis was performed as described 
in section 3.2.4. 
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4. Results 
 
Previous studies performed with mammalian cells in the group of Prof. M. Löbrich have shown that, 
following exposure to ionizing radiation, key HR proteins, such as Rad51 and Rad54, are withdrawn 
from the break site in late G2 phase and are also absent in the consequent M phase. On the other 
hand, Rad52 – the key HR protein in yeasts – is recruited in late G2 phase at the break sites and 
persists in the consequent M phase, indicating a function at the late steps of HR. 
 
Further on, in response to induced DNA DSBs, the G2 – M checkpoint is activated. Nevertheless, earlier 
published data suggests that the G2 – M checkpoint is a leaky checkpoint and that the cells enter M 
phase with HR intermediate structures (DHJs) or unrepaired DSBs. These findings suggested another 
hypothesis where it was proposed that, during the transition from G2 to M phase, Rad52 might be 
providing protection to the unrepaired DSBs and/or keeping the HR intermediate structures intact and 
thus helping the cells to carry the unfinished HR business in M phase. 
 
These interesting results led to the curiosity to understand the physiological function of Rad52 in the 
context of DSB repair mechanisms. Within the framework of this project, various experiments were 
performed to understand and characterize the role and function of Rad52 during ongoing, as well as, 
abrogated HR repair pathway following exposure to ionizing radiation. 
 
4.1. Involvement of Rad52 during Homologous Recombination in G2 and M phase 
 
4.1.1. Kinetics and quantification of Rad52-GFP foci in G2 and M phase 
 
Initially, Rad52 was identified as the key HR protein in Saccharomyces cerevisiae where it performs 
the key steps of HR, such as assembling the Rad51 filaments, strand invasion and annealing of single 
stranded DNA. Moreover, Rad52 mutants are most IR-sensitive among all S. cerevisiae single mutants 
and display a severe DSB repair defect, significantly low HR frequency, impaired viability and 
deficiency in mating-type switching (Symington, 2002). Given the important role of Rad52 in yeast, it 
came as a surprise that in vertebrates Rad52 knock out show very little phenotype with no obvious 
effect on HR. Rad52 knockout mice exhibit normal growth and development and Rad52 deficient 
embryonic stem cells are not hypersensitive to agents inducing either simple or complex DNA DSBs 
(Feng et al., 2011). 
 
As Rad52 knock-outs had no effect on HR in mice, Rad52's involvement in HR in mammalian cells was 
first investigated. To this end, HeLa tumor cells stably transfected with Rad52-GFP plasmid were used. 
HeLa-Rad52-GFP cells were grown on coverslips in a middle-sized Petridish and irradiated with 2 Gy 
of X – rays. As the HR repair pathway is active only in late S and G2 phase of the cell cycle, only those 
cells which were irradiated in G2 phase and remained in G2 phase during the entire repair incubation 
time were analyzed. In order to label and exclude S phase cells from analysis, EdU (a thymidine 
analogue which gets incorporated in the genome during replication) was added to the medium 30 min 
before irradiation and maintained throughout the entire repair incubation time. Post irradiation, cells 
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were fixed with formaldehyde (2.5 %) and harvested at various time points. Using 
Immunofluorescence (described in section 3.2.4.), the cells were stained with anti-GFP antibodies (to 
detect Rad52-GFP) and approximately 40 cells were analyzed to quantify Rad52-GFP foci. In addition, 
as a key HR marker, Rad51 was also stained to observe the ongoing HR process. 
Figure 4.1.a shows the foci kinetic for Rad52-GFP and Rad51 in G2 phase cells post 2 Gy of IR. In this 
figure (figure 4.1.a) it can be seen that Rad51 accumulated at the break site and reached its maximum 
soon (2 h) after irradiation. The number of Rad51 foci gradually declined over time indicating ongoing 
repair. On the other hand, Rad52-GFP foci exhibited opposite kinetics as compared to Rad51 foci. 
Rad52-GFP foci number gradually increased over time and reached its maximum at late time points (7 
h). This result indicates that Rad52 might be involved in the late steps of HR, i.e., post synaptic 
formation. This result is also in line with other publications where Rad52's function in late HR steps, 
such as second-end capture and strand annealing, has been discussed. 
Figure 4.1. Rad52-GFP and Rad51 foci kinetics in G2 and M phase. HeLa-Rad52-GFP cells were treated with EdU 30 min before 
irradiation with 2 Gy X-rays. The cells were then harvested at various time points post irradiation and stained with anti-GFP (to detect 
Rad52-GFP), anti-Rad51 antibodies and DAPI. Samples were scanned using Metafer software and only EdU negative G2 or M phase 
cells were analyzed. For each individual experiment ≥ 40 cells were analyzed. (A) Rad52-GFP and Rad51 foci kinetics in G2 phase post 
2 Gy irradiation. The error bars represent the SD of the mean values of two experiments. The foci number from unirradiated (0 Gy) 
samples were subtracted. (B) Rad52-GFP foci kinetics in G2 and M phase. The error bars represent the SEM of the mean values of three 
experiments. The foci number from unirradiated (0 Gy) samples were subtracted. 
It has been previously shown that Rad51 dissociates from the chromatin before the cell enters M 
phase, whereas, Rad52 persists in M phase. In order to understand the behavior of Rad52 in M phase, 
Rad52-GFP foci kinetic in M phase was analyzed. In figure 4.1.b it can be seen that in early M phase 
(Prophase) the number of Rad52-GFP foci was very similar to the foci number in late G2 phase when 
Rad52 reached its maximum. Nevertheless, the number of Rad52-GFP foci declined as the cells 
progressed through M phase and reached its lowest shortly before chromatid segregation took place. If 
this gradual decrease in Rad52-GFP foci number in M phase represents actual repair events is still an 
open question. Additionally, earlier it was shown that in M phase, along with Rad52, Mus81 is also 
present at the break sites. Mus81 is a nuclease which is well known to carry out the resolution of HR 
intermediate structures (DHJs) to finalize repair events. This indicates that apart from being involved 
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in second end capture and strand annealing, Rad52 might be actively involved in or mediating the 
processing of HR intermediate structures together with other nucleases. 
4.1.2. Kinetics of Rad52-GFP foci after hindering the early step (resection) of HR 
DSB end resection represents a key process that commits the repair of DNA DSBs to HR. In eukaryotes, 
the process of resection is initiated and carried out by the Mre11-Rad50-NBS1 (MRN) complex and C-
terminal binding protein-interacting protein (CtIP). A factor Mre11 of the MRN complex possesses 
endo- and exo-nuclease activity and functions in triggering DNA-damage checkpoints. Specifically, the 
endonuclease activity of Mre11 has been shown to initiate resection and to commit the repair of DSBs 
by HR repair pathway (Shibata et al., 2014). Further on, human CtIP is known to physically and 
functionally interact with the MRN complex to mediate the process of resection. During cell cycle, CtIP 
is regulated by the Cdks and phosphorylated by ATM and ATR in a damage dependent manner. Two 
Cdk sites on CtIP, S327 and T847, are known to regulate resection in the S and G2 phase (Sartori et 
al., 2007). 
In order to understand if the appearance of Rad52-GFP foci is a resection-dependent process, HR was 
abrogated at an early step by inhibiting resection. To inhibit resection, CtIP protein was depleted and 
the nuclease activity of Mre11 was inhibited by using siRNA technology (siCtIP) and an inhibitor 
(Mirin) respectively. Mirin is an inhibitor which is known to specifically inhibit the exonuclease activity 
of Mre11 (Shibata et al., 2014). Before irradiation, HeLa-Rad52-GFP cells were treated with siCtIP and 
Mirin to inhibit resection and harvested 2 h and 7 h post irradiation. Using immunofluorescence, the 
cells were stained for anti-GFP antibodies (to detect Rad52-GFP). In addition, Rad51 was also stained 
to observe the efficiency of siCtIP and Mirin to inhibit resection. 
Figure 4.2.a shows that, in G2 phase, the cells treated with siCtIP and Mirin had significantly low 
number of Rad51 foci compared to control cells at both time points (2 h and 7 h) post irradiation. This 
implies that by depleting CtIP and inhibiting the exonuclease activity of Mre11, there is a fall in the 
frequency of DSBs undergoing resection which is observed by the low Rad51 foci number. Further on, 
in figure 4.2.b it can be seen that siCtIP and Mirin-treatment (inhibited resection), and thus, abrogated 
HR, led to significantly low Rad52-GFP foci number at late time point (7 h) compared to control cells. 
This result indicates that appearance of Rad52-GFP foci in G2 phase is resection-dependent and that 
Rad52 has an active role in HR. 
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Figure 4.2. Rad51 and Rad52-GFP foci kinetics in G2 phase after inhibition of resection. HeLaRad52GFP cells were treated with 
siCtrl or siCtIP before irradiation with 2 Gy X-rays. Additionally, 30 min prior to irradiation EdU was added to the medium to label and 
exclude S phase cells. The cells were then harvested at various time points post irradiation and stained with anti-GFP (to detect Rad52-
GFP), anti-Rad51 antibodies and DAPI. Samples were scanned using Metafer software and only EdU negative G2 phase cells were 
analyzed. For each individual experiment ≥ 40 cells were analyzed. (A) Rad51 foci kinetics in G2 phase post 2 Gy irradiation. (B) 
Rad52-GFP foci kinetics in G2 phase. The error bars represent the SEM of the mean values of three experiments. The foci number from 
unirradiated (0 Gy) samples were subtracted. Statistical significance was tested by Student’s T-test (** = p < 0.01, * = p < 0.05). The 
siRNA efficiency was controlled by scoring Rad51 foci. 
4.1.3. Kinetics of Rad52-GFP foci after abrogating the late step of HR 
In HR repair pathway, the step of resection is followed by the loading of Rad51 nucleoprotein 
filaments on the 3'-ssDNA by BRCA2. Later on, the Rad51 nucleoprotein filaments carry out strand 
invasion in to the donor sister chromatid in order to copy the missing genetic information at the break 
site. Following strand invasion, homology search and DNA synthesis takes place and ultimately HR is 
finalized by the resolution or dissolution of the formed double Holliday junctions. However, after 
homology search and prior to resolution/dissolution, Rad51 needs to be removed from the ssDNA in 
order to allow DNA synthesis and the final steps of HR to take place (Heyer et al., 2010). 
The process of removal of Rad51 from the ssDNA is carried out by a motor protein called Rad54. There 
has been multiple roles described for Rad54 in HR mediated repair pathway but the most critical role 
is thought to be the removal of Rad51 to finalize HR events. It has been shown that, in G2 phase, 
Rad54 is phosphorylated by a kinase known as Nek1 in a damage dependent manner. Absence of 
Rad54 confers a repair defect with increased yH2AX and Rad51 foci in late G2 phase cells (Spies et al., 
2016). 
Next, the kinetics of Rad52 after depleting Rad54, and thus abrogating the late step of HR, was 
investigated. Before irradiation, HeLa-Rad52-GFP cells were treated with siRNA targeted against 
Rad54 (siRad54) and harvested 2 and 7 h post irradiation. Also, prior to irradiation, the cells were 
treated with EdU in order to label and exclude S phase cells from foci analysis. Rad52-GFP foci were 
quantified at 2 and 7 h post irradiation. Rad51 foci were additionally stained to check the efficiency of 
depletion of Rad54. 
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Figure 4.3. Rad51 and Rad52-GFP foci kinetics in G2 phase after depletion of Rad54. HeLa-Rad52-GFP cells were treated with 
siCtrl or siRad54 before irradiation. Additionally, 30 min prior to irradiation EdU was added to the medium to label and exclude S phase 
cells. The cells were then harvested at various time points post irradiation and stained with anti-GFP (to detect Rad52-GFP), anti-Rad51 
antibodies and DAPI. Samples were scanned using Metafer software and only EdU negative G2 phase cells were analyzed. For each 
individual experiment ≥ 40 cells were analyzed. (A) Rad51 foci kinetics in G2 phase post 2 Gy irradiation. (B) Rad52-GFP foci kinetics 
in G2 phase. The error bars represent the SEM of the mean values of three experiments. The foci number from unirradiated (0 Gy) 
samples were subtracted. Statistical significance was tested by Student’s T-test (*** = p < 0.001, * = p < 0.05). The siRNA efficiency 
was controlled by scoring Rad51 foci. 
As shown in figure 4.3.a, in control cells (siCtrl) the number of Rad51 foci decreased at late time point 
(7 h) post irradiation. This decrease in Rad51 foci number represents its removal by Rad54 and, as 
such, the ongoing HR-mediated repair. Consistent with Rad54's function, depletion of Rad54 
(siRad54) clearly showed much higher number of Rad51 foci at late time point post irradiation. This 
result shows that in the absence of Rad54, Rad51 cannot be removed from the ssDNA and that the 
cells are stuck with unprocessed HR intermediate structures (D-loop, DHJs). As a consequence, HR 
events cannot be finalized. This result is very much in line with other published data where it has been 
shown that, in the absence of Rad54, Rad51 foci persist in G2 phase cells. Figure 4.3.b shows that 
depletion of Rad54 resulted in significantly higher Rad52-GFP foci number at late time point (7 h) post 
irradiation as compared to control cells. This result suggests that Rad52 might bind to the ssDNA 
regions within the unprocessed HR intermediate structures and thus help to keep the structures intact 
until they are processed and repaired in the subsequent M phase or the next cell cycle phases. 
4.2. Effect of depletion of Rad52 and other HR factors (Rad51 & BRCA2) on cell proliferation 
From studies performed with S. cerevisiae, it is known that Rad52 is involved in the loading of Rad51 
nucleoprotein filaments on 3'-ssDNA and that its depletion has a severe effect on cell proliferation. On 
the contrary, in mammalian cells, the loading of Rad51 nucleoprotein filaments on 3'-ssDNA is 
performed by BRCA2. Moreover, depletion of Rad51 or BRCA2 results in the accumulation of 
chromosomal aberrations and impaired cell proliferation in mammalian cells. Interestingly, 
inactivation of Rad52 in BRCA2-deficient cells is synthetically lethal (Feng et al., 2011). In order to 
understand if Rad52 has an important physiological role during spontaneous HR, its effect on cell 
proliferation was investigated. To this end, Rad52 was depleted alone or in combination with Rad51 or 
BRCA2. 
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First, optimal conditions were established to achieve efficient depletion of Rad52 protein by siRNA. 
HeLa wt cells were treated with different concentrations of siRNA (figure 4.4.a). The siRNA sequence 
information is provided in Table 3.5 and transfection of the cells was performed as explained in section 
3.2.2. Cells were transfected twice with a gap of 24 h and harvested 24 h after the second transfection. 
In figure 4.4.a, it can be seen that the efficient depletion of Rad52 protein was achieved by transfecting 
the cells with an siRNA concentration of 50 nM. In addition, HeLa cells, stably transfected with a 
Rad52-GFP plasmid (HeLa-Rad52-GFP), were treated with 50 nM of siRNA and depletion of both 
endogenous (50 kDa) and exogenous (GFP-tagged, 80 kDa) Rad52 protein was observed (figure 
4.4.b). Furthermore, depletion of Rad52 protein in fibroblast cells (82-6) was also achieved by 
transfecting the cells with an siRNA concentration of 50 nM (figure 4.4.b.). 
To observe if the absence of Rad52 has a similar effect on cell proliferation in tumor as well as in 
healthy cell lines, HeLa tumor and 82-6 hTert fibroblast cell lines were used. Both cell lines were 
seeded separately in a 24-well plate and treated twice (with a gap of 24 h) with siRNA to deplete 
Rad52 either alone or in combination with Rad51 or BRCA2. 24 h post second siRNA transfection, the 
cells were trypsinized and the cell number was counted using a Neubauer cell counting chamber. As 
the cells in the control siRNA-treated well reached almost 80 – 90 % confluency on the 4th day, the 
cell counting was repeated consecutively for 4 days following second siRNA transfection. 
Figure 4.4.c shows that in HeLa tumor cells, treatment with control siRNA showed normal cell growth 
and depletion of Rad52 had no effect on cell proliferation; as cell growth was very similar to control 
siRNA treated cells. Depletion of Rad51 had a negative impact on cell proliferation where the cell 
growth was clearly reduced as compared to the control cells. Moreover, depletion of Rad52 and Rad51 
in combination had no additive effect. As Rad51 performs a key step of strand invasion during HR and 
is also known to provide protection to stalled and collapsed replication forks in S phase, it is not 
surprising to observe reduced cell growth in its absence. On the other hand, as Rad52 is a highly 
conserved protein and has almost 90 % similarity with its yeast homologue, it is highly surprising to 
observe that its absence has no impact on cell proliferation. Nevertheless, this data is consistent with 
previously published results where it has been shown that Rad52 deficient embryonic stem cells show 
normal cell growth and are not hypersensitive to agents that induce DSBs (Yamaguchi-Iwai, 1998). For 
82-6 hTert fibroblast cell line (figure 4.4.d) identical results were obtained in comparison to the HeLa
cell line (figure 4.4.c) upon depletion of Rad52 alone or together with Rad51. 
Depletion of BRCA2 alone impaired cell growth for both the cell lines; however, this effect was more 
severe when Rad52 was additionally depleted along with BRCA2 (figure 4.4.e and f). Indeed, cell 
growth was severely reduced when BRCA2 and Rad52 were depleted in combination (figure 4.4.e and 
f). This data suggests that in the absence of BRCA2, Rad52 plays an important physiological role and 
renders viability to cells. These results are in line with earlier published data by Feng et al. and confirm 
the relationship of synthetic lethality between Rad52 and BRCA2. However, the exact function of 
Rad52 in BRCA2-deficient cells is unclear. Further on, we set out to investigate if, in the absence of 
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BRCA2, Rad52 provides a back-up function of loading of Rad51 and/or if Rad52 is involved in 
mediating an alternative recombination mediated repair pathway. 
Figure 4.4. WB analysis of depletion of Rad52 and cell count of HeLa tumor and 82-6 hTert fibroblast cell lines. The cells were 
seeded, trypsinized each day and the cell number was counted using a Neubauer cell counting chamber.The cells were treated with 
various siRNA combinations.(A and B) Efficiency of depletion of Rad52 protein was controlled by Western Blot analysis. (C) Cell 
growth of HeLa cells after depletion of Rad52 and/or Rad51. (D) Cell growth of 82-6 hTert cells after depletion of Rad52 and/or Rad51. 
(E) Cell growth of HeLa cells after depletion of BRCA2 and/or Rad52. (F) Cell growth of 82-6 hTert cells after depletion of BRCA2
and/or Rad52. The error bars represent the SD of the mean values of two experiments.
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4.3. Role of Rad52 in the formation of ionizing radiation induced Rad51 foci 
As mentioned earlier, the loading of Rad51 on 3'-ssDNA is actively performed by BRCA2. BRCA2 
interacts with Rad51 through its 8 BRC (Breast Cancer) repeats and a region located at its C terminus 
(Chatterjee, Jimenez-Sainz, Presti, Nguyen, & Jensen, 2016). Earlier it has been published that in 
HCC1937 cells, which harbor mutation of BRCA1 but not of BRCA2, IR-induced Rad51 foci were 
readily detected. Whereas, in Capan-1 cells, which do not express functional BRCA2, very little Rad51 
foci formation was observed in response to a wide range of radiation dosages (Yuan et al., 1999). 
In this study, the involvement of Rad52 in the formation of IR-induced Rad51 foci, in the presence or 
absence of BRCA2, was next investigated. In addition, by using image analysis software ImageJ, 
colocalization of Rad52-GFP and Rad51 foci was also investigated. To this end, HeLa cells were treated 
with siRNA to deplete Rad52 and BRCA2 either alone or in combination before exposure to IR. 
Additionally, an extra sample was treated with control siRNA. The cells were harvested at various time 
points post irradiation, stained with anti-Rad51 antibodies and only EdU-negative G2 phase cells were 
analyzed. 
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Figure 4.5. Rad51 foci kinetics in G2 phase and co-localization analysis with Rad52-GFP foci. (A) Rad51 foci kinetics in G2 phase 
HeLa cells. The cells were treated with BRCA2 and/or Rad52 before irradiation with 2 Gy X-rays. Additionally, 30 min prior to 
irradiation EdU was added to the medium to label and exclude S phase cells. The cells were then harvested at various time points post 
irradiation and stained with anti-Rad51 and anti-GFP antibodies and DAPI. Samples were scanned using Metafer software and only EdU 
negative G2 phase cells were analyzed. For each individual experiment ≥ 40 cells were analyzed. The error bars represent the SEM of the 
mean values of three experiments. The foci number from unirradiated (0 Gy) samples were subtracted. Statistical significance was tested 
by Student’s T-test (** = p < 0.01, * = p < 0.05). (B) Co-localization analysis of Rad52-GFP and Rad51 foci. The cells were scanned 
using Metafer software and co-analysis was done using ImageJ software. (C) Representative images of Rad52-GFP and Rad51 foci in G2 
phase cell. The images were acquired using Metafer software. The siRNA efficiency was controlled using Western blot by Marta Llorens 
Agost. 
Post irradiation, Rad51 foci were readily detected in control cells, peaking at 2 h after IR. As time 
progressed, the number of Rad51 foci steadily decreased, corresponding to the ongoing HR mediated 
DSB repair (figure 4.5.a). As expected, in cells depleted for BRCA2, the number of Rad51 foci was 
substantially lower than in siCtrl-treated cells. On the other hand, in cells depleted for Rad52, Rad51 
foci were readily formed and the kinetics of Rad51 foci was very similar to siCtrl-treated cells. 
Furthermore, depletion of BRCA2 and Rad52 together did not have any additive negative impact on 
the formation of Rad51 foci. Moreover, image analysis showed that there was hardly any colocalization 
between Rad52-GFP and Rad51 foci (figure 4.5.b and c) indicating no interaction between Rad52 and 
Rad51. Taken together, these results clearly indicate that in mammalian G2 phase cells, Rad52 is not 
involved in the loading and formation of Rad51 foci upon IR treatment. 
Next, the function of Rad52 in providing a back-up alternative DSB repair pathway in the absence of 
BRCA2 was investigated. 
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4.4. Role of Rad52 in providing a back-up alternative DSB repair pathway in case of impaired 
Homologous Recombination 
Feng et al. (2011) have proposed that in BRCA2 deficient cells, Rad52 mediates an independent and 
alternative repair pathway of HR. They show that in the presence or absence of BRCA2, IR-induced 
and S phase associated Rad52 and Rad51 foci were readily detected. Based on these results they claim 
that Rad52 can respond to DNA DSBs and replication stalling independently of BRCA2. Therefore, the 
function of Rad52 to provide an alternative back-up repair pathway in case of impaired HR (absence of 
BRCA2) was next investigated. 
To this end, HeLa-Rad52-GFP cells were used and, before exposure to IR, treated with either control 
siRNA or siRNA targeted against BRCA2. Only those cells which were irradiated in G2 phase and 
stayed in G2 phase during the whole repair incubation time were taken into account for analysis. In 
order to label and exclude the S phase cells, half an hour prior to irradiation, EdU was added to the 
medium and left during the entire repair incubation time till harvest. Following irradiation, cells were 
harvested at different time points and stained with anti-Rad51, anti-GFP (to detect Rad52-GFP) and 
anti-yH2AX antibodies. 
As Rad51 is widely accepted as a key marker for HR, Rad51 was stained in order to observe the 
ongoing HR mechanism. As shown in figure 4.6.a, Rad51 foci were promptly detected in control siRNA 
treated samples with a steady decrease during the time course corresponding to the ongoing HR 
mediated DSB repair. As expected, depletion of BRCA2 (siBRCA2) resulted in a significant downfall in 
the number of Rad51 foci indicating an impaired HR repair process. Consequently, depletion of BRCA2 
also resulted in a repair defect in G2 phase as observed by staining yH2AX, a prominent DSB marker 
(figure 4.6.b). Interestingly, in comparison to control samples, a significantly increased numbers of 
Rad52-GFP foci were observed in BRCA2 depleted samples (figure 4.6.c and d). Moreover, at 2 h post 
irradiation, the number of Rad52-GFP foci in BRCA2 depleted samples was very similar to the number 
of Rad51 foci in control samples. This implies that in case of impaired HR (absence of BRCA2), the 
DSBs, which were supposed to undergo repair by classical Rad51-dependent HR, are decorated by 
Rad52. This result suggests that upon depletion of BRCA2, Rad52 might provide an alternative 
recombination mediated back-up repair pathway. Nevertheless, assuming that Rad52 provides a back-
up repair pathway in a BRCA2 deficient background, a repair defect is still observed at 8 h post 
irradiation, suggesting an inefficient back-up pathway to repair DSBs (figure 4.6.b). In this case, the 
function to provide protection to unrepaired DSBs by Rad52 cannot be overlooked. In order to further 
understand the function of Rad52 in detail and to figure out if Rad52 mediates a back-up repair 
pathway or protects the unrepaired resected DSBs, DSB repair kinetic was next investigated. 
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Figure 4.6. Rad52 bind to the resected DSBs in the absence of BRCA2. The cells were treated with siCtrl or siBRCA2 before 
irradiation with 2 Gy X-rays. Additionally, 30 min prior to irradiation EdU was added to the medium to label and exclude S phase cells. 
The cells were then harvested at various time points post irradiation, scanned using Metafer software and only EdU negative G2 phase 
cells were analyzed. For each individual experiment ≥ 40 cells were analyzed. (A) Rad51 foci kinetics in HeLaRad52GFP G2 phase 
cells. The cells were stained with anti-Rad51 antibodies and DAPI. (B) yH2AX foci kinetics in HeLaRad52GFP G2 phase cells. The 
cells were stained with anti-yH2AX antibodies and DAPI. (C) Rad52-GFP foci kinetics in HeLaRad52GFP G2 phase cells. The cells 
were stained with anti-GFP antibodies (to detect Rad52-GFP) and DAPI. The foci number from unirradiated (0 Gy) samples were 
subtracted. The error bars represent the SEM of the mean values of three experiments.  Statistical significance was tested by Student’s T-
test (**** = p < 0.0001, *** = p < 0.001, ** = p < 0.01, * = p < 0.05). (D) Representative images of Rad52-GFP foci in siCtrl and 
siBRCA2-treated G2 phase cells at 2h post 2 Gy IR. The images were acquired using Metafer software. The siRNA efficiency was 
controlled by scoring Rad51 foci. 
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4.5. Double strand break repair kinetics 
4.5.1. Double strand break repair kinetics in G2 phase 
The yH2AX foci are widely accepted as a DSB marker and represent the DSBs in a 1:1 ratio. By using 
the yH2AX assay, the kinetics of DSB repair was analyzed. To this end, HeLa tumor cells, wt 82-6 hTert 
and BRCA2 mutant HSC-62 hTert fibroblast cell lines were used. Prior to irradiation, the cells were 
treated with siRNA against BRCA2 and Rad52. As in previous experiments, for this experiment also, 
only those cells, which were irradiated in G2 phase and stayed in G2 phase during the whole repair 
incubation time, were analyzed. The cells were stained with anti-yH2AX antibodies and approximately 
40 cells were analyzed to quantify unrepaired DSBs. 
Consistent with previous reports, in comparison to control siRNA (siCtrl) treated cells, depletion of 
BRCA2 (siBRCA2) in HeLa cells displayed impaired DSB repair, resulting in more residual yH2AX foci 
at 8 h post 2 Gy (figure 4.7). Depletion of Rad52 (siRad52) had no effect on DSB repair and the breaks 
were repaired efficiently as in siCtrl treated cells. Assuming that Rad52 mediates an alternative back-
up repair pathway, one might expect an additive repair defect upon co-depletion of BRCA2 and Rad52 
as both the repair pathways (classical HR and a back-up repair pathway) would be unavailable for the 
cell. Interestingly, upon depletion of BRCA2 and Rad52 together, no additive DSB repair defect was 
displayed. Instead, double depletion of BRCA2 and Rad52 led to the rescue of the BRCA2 repair defect 
and, as a consequence, an efficient repair was observed where the number of residual yH2AX foci was 
similar to siCtrl treated cells (figure 4.7). 
Figure 4.7. Co-depletion of BRCA2 and Rad52 rescues the BRCA2 repair defect in HeLa cells. The cells were treated with siCtrl or 
siBRCA2 and/or siRad52 before irradiation with 2 Gy X-rays.30 min prior to irradiation EdU was added to the medium to label and 
exclude S phase cells. The cells were then harvested at various time points post irradiation and stained with anti- yH2AX antibodies and 
DAPI. Samples were scanned using Metafer software and only EdU negative G2 phase cells were analyzed. For each individual 
experiment ≥ 40 cells were analyzed. The foci number from unirradiated (0 Gy) samples were subtracted. The error bars represent the 
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SEM of the mean values of three experiments. Statistical significance was tested by Student’s T-test (* = p < 0.05).The siRNA efficiency 
was controlled by Western blot (performed by Marta Llorens Agost). 
Similar results were observed when the experiment was conducted with wt 82-6 hTert and BRCA2 
mutant HSC-62 hTert fibroblast cell lines (figure 4.8.a and b). As observed with HeLa cells, depletion 
of BRCA2 (siBRCA2) in wt 82-6 hTert cells displayed a repair defect, whereas, co-depletion of BRCA2 
and Rad52 resulted in the rescue of the BRCA2 repair defect at 8 h post 2 Gy (figure 4.8.a). BRCA2 
mutant HSC-62 hTert fibroblasts displayed an impaired repair at 8 h post irradiation compared to wt 
82-6 hTert fibroblasts (figure 4.8.b). Importantly, upon depletion of Rad52 in HSC-62 fibroblasts, the
BRCA2 repair defect was rescued (figure 4.8.b). In order to represent and explain the results in a more 
clear fashion, data only from fibroblast (82-6 & HSC-62) cell lines is shown until section 4.7. 
Figure 4.8. Depletion of Rad52 in BRCA2-mutant cells rescues the BRCA2 repair defect. 30 min prior to irradiation (2 Gy X-rays) 
EdU was added to the medium to label and exclude S phase cells. The cells were then harvested at various time points post irradiation 
and stained with anti-yH2AX antibodies and DAPI. Samples were scanned using Metafer software and only EdU negative G2 phase cells 
were analyzed. For each individual experiment ≥ 40 cells were analyzed. (A) yH2AX foci kinetics in 82-6 hTert G2 phase cells. The cells 
were treated with siCtrl or siBRCA2 and/or siRad52before irradiation. (B) yH2AX foci kinetics in 82-6 hTert and HSC-62 hTert G2 
phase cells. The cells were treated with siCtrl or siRad52 before irradiation. The foci number from unirradiated (0 Gy) samples were 
subtracted. The error bars represent the SEM of the mean values of three experiments. Statistical significance was tested by Student’s T-
test (** = p < 0.01,* = p < 0.05). The siRNA efficiency was controlled by Western blot. 
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4.5.2. Double strand break repair kinetics in S phase 
The shift from c-NHEJ to HR is gradual, with the highest proportion of DSBs being repaired by HR in 
mid-S phase where the amount of DNA replication is at its peak (Karanam, Kafri, Loewer, & Lahav, 
2012). In G2 phase, approximately 20 % of the DSBs are repaired by HR. After ascertaining that in G2 
phase, co-depletion of BRCA2 and Rad52 leads to the rescue of the BRCA2 repair defect, we next set 
out to investigate if this phenomenon is also true for S phase where the contribution of HR is much 
higher than in G2 phase. For this purpose, wt 82-6 hTert and BRCA2 mutant HSC-62 hTert fibroblast 
cell lines were used. DSBs were induced in the cells randomly by exposure to IR or specifically in S 
phase by treatment with camptothecin (CPT). CPT is a topoisomerase I inhibitor which forms a 
complex with topoisomerase I and ssDNA. Upon collision of this complex with a replication fork, S 
phase specific DSBs are generated. 
Prior to exposure to IR or treatment with CPT, BRCA2 and Rad52 proteins were depleted either alone 
or in combination using the siRNA technology. For this experiment, only EdU labeled S phase cells 
were taken into account for foci quantification, whereas, G1 and G2 phase cells were excluded from 
the analysis. Using immunofluorescence, the cells were stained with anti-yH2AX antibodies and 
approximately 40 S phase cells were analyzed to quantify unrepaired DSBs. 
In wt 82-6 hTert fibroblasts, depletion of Rad52 (siRad52) had no effect on DSB repair in S phase at 8 
h post 2 Gy irradiation or CPT treatment (figure 4.9.a and b). In BRCA2 mutant HSC-62 hTert cells, a 
repair defect was observed at 8 h post 2 Gy irradiation or CPT treatment, displayed by an increased 
number of residual yH2AX foci compared to wt 82-6 hTert fibroblast cells (figure 4.9.c and d). 
Moreover, the repair defect observed in BRCA2 mutant HSC-62 hTert cells was rescued upon depletion 
of Rad52 (figure 4.9.c and d). This observation was true for both the cases: damage induced by 
exposure to IR or by CPT treatment (figure 4.9.c and d). Henceforth, consistent with the results 
obtained for G2 phase (figure 4.8.a and b), the phenomenon of rescue of the BRCA2 repair defect 
upon depletion of Rad52 was also observed and validated for S phase (figure 4.9.c and d). 
These results taken together suggest that, in case of impaired HR during S and/or G2 phase, rather 
than mediating an alternative repair pathway, Rad52 provides some sort of protection to the 
unrepaired breaks. This function of Rad52 is very much likely to protect the resected 3'-ssDNA from 
being degraded by the action of some nucleases or to prevent an erroneous pathway from acting upon 
the resected DNA breaks. Further on, the repair pathway responsible for the repair of DSBs in the 
absence of BRCA2 and Rad52 was next investigated. To this end, G2 phase-specific experiments were 
performed where only those cells, which were in G2 phase at the time of harvest, were analyzed. 
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Figure 4.9. Rescue of the BRCA2 repair defect in S phase. Cells were treated with siCtrl or siRad52 and 30 min prior to irradiation (2 
Gy X-rays) EdU was added to the medium to label S phase cells. The cells were then harvested at various time points post irradiation and 
stained with anti- yH2AX antibodies and DAPI. Samples were scanned using Metafer software and only EdU positive S phase cells were 
analyzed. For each individual experiment ≥ 40 cells were analyzed. (A) yH2AX foci kinetics in 82-6 hTert S phase cells after irradiation 
with 2 Gy X-rays. (B) yH2AX foci kinetics in 82-6 hTert S phase cells after treatment with 20 nM CPT. (C) yH2AX foci kinetics in 
HSC-62 hTert S phase cells after irradiation with 2 Gy X-rays. (D) yH2AX foci kinetics in HSC-62 hTert S phase cells after treatment 
with 20 nM CPT. The foci number from unirradiated (0 Gy) samples were subtracted. The error bars represent the SEM of the mean 
values of three experiments. Statistical significance was tested by Student’s T-test (** = p < 0.01). The siRNA efficiency was controlled 
by Western blot (supplement figure 6.3). 
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4.5.3. Involvement of theta-mediated end joining in the rescue of BRCA2 repair defect upon 
Rad52 depletion in G2 phase 
Increasing evidence suggest that HR-deficient tumor cells are dependent on Polθ-mediated repair for 
their survival (Ceccaldi, Liu, et al., 2015). Polθ functions by annealing the microhomologies (MHs) 
present within the resected 3'-ssDNA and, thus, mediates TMEJ repair pathway (Kent et al., 2015). 
Molecular characterization has revealed that PARP1 and Ligase3 are also involved in TMEJ repair 
pathway (Sfeir & Symington, 2015). 
To figure out if TMEJ is responsible for the repair of DSBs in the absence of BRCA2 and Rad52, DSB 
repair kinetic experiments were performed after inhibiting or depleting TMEJ factors (PARP & Polθ). 
To this end, primary fibroblast (wt 82-6 & BRCA2 mutant HSC-62) cell lines were used. Before 
irradiation, Rad52 or Polθ were depleted using siRNAs and PARP was inhibited using an inhibitor 
called Olaparib. 8 h post 2 Gy of IR, cells were harvested, fixed with 2.5 % formaldehyde, stained with 
anti-yH2AX antibodies and only EdU negative G2 phase cells were analyzed. 
Figure 4.10. BRCA2 repair defect is rescued by Polθ-dependent TMEJ. 30 min prior to irradiation EdU was added to the medium to 
label and exclude S phase cells from analysis. The cells were then harvested at 8 h post irradiation and stained with anti- yH2AX 
antibodies and DAPI. Samples were scanned using Metafer software and only EdU negative G2 phase cells were analyzed. For each 
individual experiment ≥ 40 cells were analyzed. (A) yH2AX foci kinetics in 82-6 hTert G2 phase cells. Before irradiation, the cells were 
treated with siRad52 and/or PARPi (1 µM Olaparib). (B) yH2AX foci kinetics in 82-6 hTert G2 phase cells. Before irradiation, the cells 
were treated with siRad52 and/or siPolθ. (C) yH2AX foci kinetics in HSC-62 hTert G2 phase cells. Before irradiation, the cells were 
0 
2 
4 
6 
8 
10 
12 
A
v
er
a
g
e 
#
 o
f 
yH
2
A
X
 
fo
ci
 p
er
 c
el
l 
8 
Time (h) post 2 Gy IR 
82-6, G2
siCtrl 
siRad52 
PARPi 
siRad52+PARPi 
A 
0 
2 
4 
6 
8 
10 
12 
A
v
er
a
g
e 
#
 o
f 
yH
2
A
X
 
fo
ci
 p
er
 c
e
ll
 
8 
Time (h) post 2 Gy IR 
82-6, G2
siCtrl 
siRad52 
siPolQ 
siRad52+siPolQ 
B 
0 
5 
10 
15 
20 
25 
A
v
er
a
g
e 
#
 o
f 
yH
2
A
X
 
fo
ci
 p
er
 c
el
l 
8 
Time (h) post 2 Gy IR 
HSC-62, G2 
siCtrl 
siRad52 
PARPi 
siRad52+PARPi 
** 
C 
0 
5 
10 
15 
20 
25 
A
v
er
a
g
e 
#
 o
f 
yH
2
A
X
 
fo
ci
 p
er
 c
el
l 
8 
Time (h) post 2 Gy IR 
HSC-62, G2 
siCtrl 
siRad52 
siPolQ 
siRad52+siPolQ 
** 
D 
Results 49 
treated with siRad52 and/or PARPi (1 µM Olaparib). (D) yH2AX foci kinetics in HSC-62 hTert G2 phase cells. Before irradiation, the 
cells were treated with siRad52 and/or siPolθ. The foci number from unirradiated (0 Gy) samples were subtracted. The error bars 
represent the SEM of the mean values of three experiments. Statistical significance was tested by Student’s T-test (** = p < 0.01). 
As shown in figure 4.10.a and b, inhibition of PARP or depletion of Rad52 or Polθ had no impact on 
the repair of DSBs in wt 82-6 G2 phase cells. Also, inactivation of PARP or Polθ together with Rad52 
displayed no impaired DSB repair kinetic. For all the above mentioned conditions, the residual yH2AX 
foci number was similar to control-siRNA (siCtrl) treated cells (figure 4.10.a and b). Figure 4.10.c and 
d show that, at 8 h post irradiation, siCtrl treated BRCA2 mutant HSC-62 cells showed a repaired 
defect observed by substantial increase in number of residual yH2AX foci compared to wt 82-6 cells. 
Indeed, this repair defect was rescued upon depletion of Rad52. Like in wt 82-6 cells, in BRCA2 
mutant HSC-62 cells inactivation of PARP or Polθ had no impact on the repair of DSBs neither an 
additive repair defect was observed (figure 4.10.c and d). Importantly, depletion of Rad52 together 
with inactivation of PARP or Polθ did not result in the rescue of the BRCA2 repair defect (figure 4.10.c 
and d) which is displayed by an increased number of residual yH2AX foci as compared to Rad52 
depleted situation. These results indicate that, in BRCA2-deficient cells, absence of Rad52 leads to the 
repair of DSBs by TMEJ repair pathway mediated by PARP and Polθ, and, as such, rescues the BRCA2 
repair defect. In other words, presence of Rad52 in BRCA2 deficient cells prevents TMEJ repair 
pathway from acting upon the unrepaired DSBs. 
4.6. Kinetics of replication protein A in G2 phase during the rescue of BRCA2 repair defect 
TMEJ and HR repair pathways share a common initial step of resection (Truong et al., 2013). Deng et 
al. (2014) showed that the process of resection exposes the MHs present along the stretch of 3'-ssDNA. 
Furthermore, the presence of RPA on the ssDNA prevents spontaneous annealing between MHs. Thus, 
RPA antagonizes TMEJ and channels the repair of DSBs from TMEJ to HR (Deng, Gibb, de Almeida, 
Greene, & Symington, 2014). 
After establishing the fact that in G2 phase upon co-depletion of BRCA2 and Rad52 repair of DSBs is 
channeled to TMEJ, the presence of RPA bound to ssDNA and its effect on TMEJ-mediated repair 
pathway was next investigated. To this end, fibroblasts 82-6 and HSC-62 cells were used and depleted 
for BRCA2 and Rad52 before exposure to IR. Immunofluorescence staining of RPA phosphorylated at 
Threonine21 (pRPA pT21) can detect ssDNA bound RPA which is readily visible as foci in S/G2 phase. 
As such, the cells were stained with anti-pRPA (pT21) antibodies and only EdU negative G2 phase 
were analyzed for foci quantification. 
As presented in figure 4.11.a, pRPA foci were readily detected in siCtrl-treated 82-6 G2 phase cells at 2 
h post 2 Gy IR. In these cells, the number of pRPA foci clearly decreased at 6 h post 2 Gy IR 
corresponding to HR mediated repair of DSBs. After depleting Rad52, no effect on the kinetics of pRPA 
foci was observed. On the other hand, in siCtrl-treated HSC-62 cells, a clearly higher number of pRPA 
foci was observed at 2 h post 2 Gy IR compared to 82-6 cells. Additionally, instead of decreasing, this 
high pRPA foci number was maintained throughout the entire repair incubation time which refers to a 
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repair defect due to mutant BRCA2 in HSC-62 cells. Interestingly, the high amount of pRPA foci was 
significantly reduced upon depletion of Rad52 at both 2 and 6 h post irradiation in HSC-62 cells 
(figure 4.11.a). Furthermore, upon depletion of Rad52 together with Polθ, no reduction in pRPA was 
observed (figure 4.11.b). This observed pRPA kinetics corresponds well the DSB repair kinetic where 
no reduction of yH2AX foci was observed upon co-depletion of Rad52 and Polθ (figure 4.10.d). These 
results suggest that in the absence of BRCA2 and Rad52, there is less RPA bound to ssDNA (shown by 
reduced pRPA foci number; figure 4.11.a), which exposes the MHs and allows TMEJ-mediated repair 
of DSBs. However, it is still an open question if the reduction in pRPA foci number is due to the 
absence of BRCA2 and Rad52 or due to repair itself (mediated by TMEJ). 
Figure 4.11. Removal of RPA facilitates TMEJ. 30 min prior to irradiation (2 Gy X-rays) EdU was added to the medium to label and 
exclude S phase cells from analysis. The cells were then harvested at various time points post irradiation and stained with anti-pRPA 
antibodies and DAPI. Samples were scanned using Metafer software and only EdU negative G2 phase cells were analyzed. For each 
individual experiment ≥ 40 cells were analyzed. (A) pRPA foci kinetics in 82-6 hTert and HSC-62 hTert G2 phase cells. Before 
irradiation, the cells were treated with siCtrl or siRad52. The error bars represent the SEM of the mean values of three experiments. (B) 
pRPA foci kinetics in HSC-62 hTert G2 phase cells. Before irradiation, the cells were treated with siCtrl or siRad52 and/or siPolθ. The 
error bars for siCtrl and siRad52 represent the SEM of the mean values of three experiments and for siPolQ and siRad52+siPolQ 
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represent the SD of the mean values of two experiments. The foci number from unirradiated (0 Gy) samples were subtracted. Statistical 
significance was tested by Student’s T-test (*** = p < 0.001, ** = p < 0.01, * = p < 0.05). The siRNA efficiency for depletion of Rad52 
protein was controlled by Western blot. 
4.7. Chromosomal studies 
4.7.1. Effect of Rad52 on chromosomal rearrangements 
As presented in section 3.5., in wild type cells, presence or absence of Rad52 has no effect on the 
repair of DSBs. However, in a BRCA2-deficient background, availability of Rad52 does make a 
difference as its presence confers a repair defect, whereas, its absence leads to repair mediated by 
TMEJ (figure 4.8.b). Furthermore, it has been shown and discussed in many peer reviewed 
publications that TMEJ-mediated repair gives rise to chromosomal rearrangements and thus causes 
genomic instability (Ceccaldi,  Liu, et al. ,  2015; Ceccaldi,  Rondinelli ,  & D’ Andrea, 2015; 
Sfeir & Symington, 2015; D. W. Wyatt et al. ,  2016) .Therefore, the effect of presence or 
absence of Rad52 on chromosomal rearrangements was next investigated. DSBs were induced either 
by exposure to IR or by treatment with CPT (S phase specific damage). 
For this purpose, premature chromosome condensation assay (PCC) was performed. PCC is a widely 
used method which allows drug-induced premature condensation of interphase chromatin and makes 
them visible as mitotic chromosomes. Human fibroblast (wt 82-6 and BRCA2 mutant HSC-62) cell 
lines were used and depleted for Rad52 (siRad52) before 2 Gy irradiation or CPT treatment and 
harvested 8 – 10 h after irradiation.  Calyculin A (50 ng / ml medium) was added to the medium 30 
min before harvesting. 
Figure 4.12. Representative images of Calyculin A-induced G2 phase PCC spreads of 82-6 hTert cells showing chromatid breaks 
(A) and chromatid fusions (B). The cells were irradiated with 2 Gy X-rays and harvested at 8 – 10 h post exposure to IR. 30 min prior
to harvest, Calyculin A (50 ng / ml) was added to the medium to induce PCC. The cells were treated with 75 mM KCl and fixed with 3:1
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methanol – acetic acid solution. Chromosome spreads were prepared by dropping the cells on a microscopic slide and staining the 
chromosomes with Giemsa stain. The chromosome spreads were scanned and the images were acquired using Metafer software. 
Chromatid breaks represent unrepaired breaks, whereas, chromatid fusions represent mis-rejoining of 
chromosomal ends (chromosomal rearrangement; figure 4.12.a and b). For IR-treatment, in wt 82-6 
cells, depletion of Rad52 had no effect on the repair of chromatid breaks as the number of unrepaired 
breaks at 8h post 2 Gy IR was similar to control-siRNA (siCtrl) treated cells. As expected, siCtrl-treated 
HSC-62 cells showed higher number of unrepaired chromatid breaks when compared to wt 82-6 cells, 
displaying a repair defect. Interestingly, this repair defect was rescued upon depletion of Rad52, 
displayed by similar number of residual chromatid breaks as compared to 82-6 cells (figure 4.13.a). 
The chromatid break analysis data is in line with the yH2AX foci kinetic data, where a rescue of the 
BRCA2 repair defect was observed upon depleting Rad52 (figure 4.8.b). More importantly, in HSC-62 
cells, a clear increase in the number of chromatid fusions was observed when Rad52 was depleted 
(figure 4.13.b). Similar results were observed for the cells treated with CPT (figure 4.13.c and d). This 
indicates that in a BRCA2-deficient background, absence of Rad52 results in a clear increase in 
chromatid fusions. In other words, the rescue of the BRCA2 repair defect by depleting Rad52 occurs at 
the cost of chromosomal fusions which are, most likely, the product of TMEJ-mediated repair. 
Figure 4.13. Rescue of the BRCA2 repair defect increases chromosomal fusions. Prior to exposure to IR or CPT treatment, the cells 
were treated with siCtrl or siRad52. 30 min prior to harvest, Calyculin A (50 ng / ml) was added to the medium to induce PCC. The cells 
were then treated with 75 mM KCl and fixed with 3:1 methanol – acetic acid solutionat 8 – 10 h post treatment. Chromosome spreads 
were prepared by dropping the cells on a microscopic slide and staining the chromosomes with Giemsa stain. The chromosome spreads 
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were scanned using Metafer software. For each individual experiment ≥ 40 chromosomal spreads were analyzed. (A) The average 
number of residual chromatid breaks post 2 Gy IR. (B) The average number of residual chromatid fusions post 2 Gy IR. (C) The average 
number of residual chromatid breaks post CPT treatment. (D) The average number of residual chromatid fusions post CPT treatment. 
The chromatid break and fusion numbers from unirradiated (0 Gy) samples were subtracted. The error bars represent the SD of the mean 
values of two experiments. The siRNA efficiency was controlled by Western blot (as shown in figure 4.11). 
4.7.2. Effect of Rad52 and Polymerase-theta (Polθ) on chromosomal rearrangements 
As learned from DSB repair kinetics data, in BRCA2 deficient cells, depletion of Polθ and Rad52 
together does not lead to the activation of TMEJ repair pathway, and as a consequence, does not 
rescue the BRCA2 repair defect (figure 4.10.d). Hence, the effect of depletion of Polθ and Rad52 on 
chromosomal rearrangements in BRCA2 proficient and deficient cells was next investigated. To this 
end, human fibroblast (wt 82-6 and BRCA2 mutant HSC-62) cell lines were used and, prior to 
irradiation, the cells were depleted for Rad52 or Polθ or both in combination. Following this, PCC 
assay was performed using Calyculin A and G2 phase chromosome spreads were analyzed for 
chromatid breaks and fusions. 
Similar to the DSB repair kinetic data (figure 4.10.b), no impact of depletion of Polθ or Rad52 or their 
co-depletion was observed on chromatid breaks or fusions in wt 82-6 cells (figure 4.14.a and b). 
Showing a repair defect, HSC-62 cells displayed more residual chromatid breaks compared to 82-6 
cells and, as expected, this repair defect was rescued upon depletion of Rad52 (figure 4.14.c). 
Furthermore, co-depletion of Rad52 and Polθ did not lead to the rescue of the repair defect, displayed 
by a higher number of residual chromatid breaks when compared to Rad52 depleted situation (figure 
4.14.c). This data is consistent with the DSB repair kinetic data (figure 4.10.d) and confirms the 
finding that, in the absence of BRCA2 and Rad52, the rescue of the repair defect is carried out by the 
Polθ-dependent TMEJ repair pathway. 
Figure 4.14.d shows the chromatid fusion data in BRCA2 mutant HSC-62 cells upon depletion of 
Rad52 or Polθ or both together. As expected, depletion of Rad52 showed increased number of 
chromatid fusions as compared to siCtrl-treated cells, which is most likely due to the activation of 
TMEJ repair pathway. Interestingly, depletion of Polθ alone or together with Rad52 gave rise to 
significantly increased number of chromatid fusions as compared to siCtrl or siRad52-treated HSC-62 
cells (figure 4.14.d). This finding was highly surprising because earlier (figure 4.13.b and d) it was 
observed that the formation of chromatid fusions was Polθ-dependent and, therefore, one might expect 
the number of chromatid fusions to decrease in the absence of Polθ. Nevertheless, this finding suggests 
that c-NHEJ might rejoin the chromosomal ends and form chromatid fusions when both the 
recombination mediated repair pathway – HR (BRCA2) & TMEJ (Polθ) – are unavailable for the cells. 
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Figure 4.14. Chromosomal fusions are formed in a Polθ-dependent manner. Prior to exposure to 2 Gy IR, the cells were treated with 
siCtrl or siRad52 and/or siPolθ. 30 min prior to harvest, Calyculin A (50 ng / ml) was added to induce G2 phase PCC. The cells were 
then treated with 75 mM KCl and fixed with 3:1 methanol – acetic acid solution 8h post IR. Chromosome spreads were prepared by 
dropping the cells on a microscopic slide and staining the chromosomes with Giemsa stain. The chromosome spreads were scanned using 
Metafer software. For each individual experiment ≥ 40 chromosomal spreads were analyzed. (A) The average number of residual 
chromatid breaks in 82-6 hTert cells. (B) The average number of residual chromatid fusions in 82-6 hTert cells. (C) The average number 
of residual chromatid breaks in HSC-62 hTert cells. (D) The average number of residual chromatid fusions in HSC-62 hTert cells. The 
chromatid break and fusion numbers from unirradiated (0 Gy) samples were subtracted. The error bars represent the SEM of the mean 
values of three experiments. Statistical significance was tested by Student’s T-test (*** = p < 0.001, ** = p < 0.01). 
4.8. Interplay of Rad52, BRCA2 and Polymerase-theta in tumor cells 
4.8.1. Impact of Rad52, BRCA2 and Polymerase-theta on DSB repair kinetics in tumor cells 
Upon validating the result that, in BRCA2-deficient human fibroblast cell lines, depletion of Rad52 
leads to the rescue of the BRCA2 repair defect by Polθ-dependent TMEJ repair pathway at the cost of 
chromosomal fusions, the impact of these factors (Rad52, BRCA2 &Polθ) on DSB repair kinetic in 
tumor cells was next investigated. For this purpose, HeLa tumor cells (cervix carcinoma) were used 
and depleted for Rad52, BRCA2 or Polθ in different combinations and yH2AX foci were quantified. 
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Figure 4.15. HR and TMEJ are active simultaneously in G2 phase HeLa cells. HeLa cells were treated with siCtrl, siRad52, 
siBRCA2 and siPolθ in various combinations before irradiation with 2 Gy X-rays. Only EdU-positive-BrdU-negative G2 phase cells 
were analyzed. The cells were stained with anti-yH2AX antibodies and DAPI. Samples were scanned using Metafer software. For each 
individual experiment ≥ 40 cells were analyzed. The foci numbers from unirradiated (0 Gy) samples were subtracted. The error bars 
represent the SEM of the mean values of three experiments. Statistical significance was tested by Student’s T-test (** = p < 0.01, * = p < 
0.05). The siRNA efficiency was controlled by Western blot (performed by Na Wei). 
Figure 4.15 represents the average number of unrepaired DSBs (yH2AX foci) in HeLa G2 phase cells. 
As observed earlier (figure 4.7), in figure 4.15 it can be observed that in G2 phase HeLa cells depletion 
of Rad52 did not affect repair, depletion of BRCA2 displayed an impaired repair and, co-depletion of 
Rad52 and BRCA2 rescued the BRCA2 repair defect.  
Interestingly, unlike fibroblast cell lines, depletion of Polθ in HeLa cells showed a repair defect in G2 
phase cells (8 h post IR) and, moreover, a huge additive repair defect was observed upon co-depletion 
of BRCA2 and Polθ (figure 4.15). This result suggests that in G2 phase tumor cells, the two resection-
dependent pathways (HR & TMEJ) are simultaneously active and, to most of the extent, can 
compensate for each other. However, even though the two pathways (HR & TMEJ) are available in G2 
phase, depletion of a factor from either of the pathways results in a repair defect. Furthermore, an HR 
repair defect (due to the absence of BRCA2) is indeed rescued by Polθ-dependent TMEJ pathway upon 
depleting Rad52. This suggests that the presence of Rad52, in BRCA2-deficient tumor cells, makes sure 
that a “special sub-class” of DSBs (long resected DSBs) which are committed to HR do not undergo 
repair by the erroneous TMEJ repair pathway. 
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4.8.2. Impact of Rad52, BRCA2 and Polymerase-theta on chromosomal aberrations 
After learning that in tumor cells both HR and TMEJ are distinctively active and that, in case of 
abrogated HR, presence of Rad52 prevents the repair of HR-committed DSBs by TMEJ repair pathway, 
the impact of Rad52 and Polθ on chromosomal aberrations in BRCA2 proficient and deficient tumor 
cells was next investigated. To this end, HeLa cells were used and, prior to irradiation, depleted for 
Rad52, BRCA2 or Polθ either alone or in combination with each other. Following exposure to 2 Gy IR, 
Calyculin A-induced PCC assay was performed and only G2 phase chromosome spreads were analyzed 
for chromatid breaks and fusions. 
As observed for primary fibroblast cell lines, in HeLa cells as well, depletion of Rad52 had no effect on 
the repair of chromatid breaks, whereas, depletion of BRCA2 resulted in a repair defect displayed by 
an increased number of unrepaired chromatid breaks as compared to siCtrl-treated cells (figure 
4.16.a). Indeed, the BRCA2 repair defect was rescued upon co-depletion of Rad52 and BRCA2 (figure 
4.16.a). Additionally, it was observed that the rescue of the repair defect (BRCA2+Rad52 depleted 
situation) occurred at the expense of increased number of chromatid fusions (figure 4.16.b). These 
results support previous findings from fibroblast cell lines, where it was observed that absence of 
BRCA2 and Rad52 results in increased number of chromatid fusions, which are most likely the 
products of the TMEJ repair pathway (figure 4.13.b). 
Consistent with the DSB repair (yH2AX foci) kinetics data, depletion of Polθ alone showed a repair 
defect in G2 phase with increased number of unrepaired chromatid breaks compared to siCtrl-treated 
cells (figure 4.16.a). Co-depletion of Rad52 and Polθ did not have any additive effect on the number of 
unrepaired chromatid breaks (figure 4.16.a). Likewise, Rad52-depletion and Rad52+Polθ co-depletion 
had no impact on chromatid fusion numbers, however, a slight increase in chromatid fusion numbers 
was observed when Polθ was depleted alone (figure 4.16.b). 
Furthermore, co-depletion of BRCA2 and Polθ resulted in an additive repair defect (figure 4.16.a). 
These results are in line with the yH2AX foci kinetic data, where an additive repair defect was 
observed upon co-depletion of BRCA2 and Polθ (figure 4.15). Further on, as observed for fibroblast cell 
lines, co-depletion of BRCA2 and Polθ in Hela cells resulted in a significant increase in the number of 
chromatid fusions. This result suggests that, in case of impaired HR (BRCA2 deficiency) and TMEJ 
(Polθ deficiency), DNA break ends are joined and misrepaired leading to formation of chromosomal 
fusions. It is highly likely that, in this specific scenario (BRCA2+Polθ depletion), c-NHEJ repair 
pathway might be responsible for giving rise to chromosomal fusions. This finding is consistent with 
previously published data, where it has been shown that in BRCA2 deficient tumor cells, depletion of 
Polθ leads to an increase in chromosomal abnormalities in c-NHEJ-dependent manner (Mateos-Gomez 
et al., 2015). 
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Figure 4.16. In the absence of HR and TMEJ, c-NHEJ forms chromosomal fusions. Before irradiation (2 Gy), HeLa cells were 
treated with siCtrl, siRad52, siBRCA2 and siPolQ in various combinations. 30 min prior to harvest, Calyculin A (50 ng / ml) was added 
to the medium to induce PCC. The cells were then treated with 75 mM KCl and fixed with 3:1 methanol – acetic acid solution at 8h post 
IR. Chromosome spreads were prepared by dropping the cells on a microscopic slide and staining the chromosomes with Giemsa stain 
and were scanned using Metafer software. For each individual experiment ≥ 40 chromosomal spreads were analyzed. (A) The average 
number of residual chromatid breaks in HeLa cells. (B) The average number of chromatid fusions at in HeLa cells. The error bars 
represent the SD of the mean values of two experiments. The chromatid break and fusion numbers from unirradiated (0 Gy) samples 
were subtracted. The siRNA efficiency was controlled by Western blot (shown in figure 4.15). 
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4.9. DSB repair kinetics in G1 phase cells following IR-treatment in the previous G2 phase 
In section 4.8 it was observed that, in HeLa cells, the two resection-dependent pathways (HR & TMEJ) 
are active simultaneously in G2 phase. Nevertheless, presence of Rad52 in BRCA2-depleted cells 
prevents the repair of HR-committed breaks by the erroneous TMEJ repair pathway. Next, the effect of 
Rad52 on the fate of DSBs in BRCA2-proficient and deficient G1 phase cells was investigated. To this 
end, HeLa cells were used and depleted for Rad52, BRCA2 and Polθ in various combinations. The cells 
were irradiated in G2 phase and arrested in G2 and the consequent G1 phase. The cell cycle 
distribution and the position of the cells (G2 or G1 phase) during analysis is shown and explained in 
the following sections. 
4.9.1. Cell cycle distribution 
As explained in section 3.2.6, HeLa cells were double-labeled with EdU and BrdU and the G2 phase 
irradiated cells were arrested in the consequent G1 phase. In brief, the cells were pulse-labeled with 
EdU for 1 h and stored in an incubator for an additional 1 h. The total time of 2 h allowed a small 
population of late-S phase-EdU-positive cells to traverse in to G2 phase. Next, the cells were treated 
with BrdU for 1 h before irradiation and the BrdU was maintained in the medium throughout the 
repair incubation time.  This allowed the S phase cells and the fresh S phase cell population coming 
from G1 phase to be labeled as either EdU+BrdU-positive or BrdU-positive respectively. By using semi-
automated Metafer software, the cells were scanned for EdU and BrdU. Only EdU-positive-BrdU-
negative cells (EdU-positive cells irradiated in G2 phase) were gated and analyzed. The cell cycle 
distribution and the gated cells can be seen in figure 4.17. 
Figure 4.17. Horse shoe-shaped diagram of EdU vs DAPI and BrdU vs DAPI. HeLa cells were irradiated with 2 Gy IR, fixed with 
2.5% formaldehyde and stained for EdU, BrdU and DAPI. At 10 and 12 h post IR, a small peak of EdU-positive G1 phase cells can be 
seen. 
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The exact position of each analyzed cell, present in the gated box, can be seen in figure 4.18.a-c. At 8 h 
post irradiation, the analyzed EdU-positive cells (shown in red) were in G2 phase, represented as a 
function of DAPI on the X-axis (figure 4.18.a). Later on, at 10 and 12 h post irradiation, an extra peak 
of EdU-positive cells was observed as shown in figure 4.17. The exact position of the analyzed EdU-
positive cells (shown in red) at 10 and 12 h post irradiation is shown in figure 4.18.b and c, where it 
can be observed that the analyzed cells were in G1 phase, represented as a function of DAPI on the X-
axis. 
Figure 4.18. Exact cell cycle phase position of selected EdU-positive-BrdU-negative cells. The position of analyzed cells (shown in 
red) at 8 h post IR is in G2 phase, represented as a function of DAPI (A). Similarly, at 10 And 12 h post IR, it can be seen that the 
analyzed cells were in G1 phase (B and C). 
4.9.2. DSB repair kinetics in G2 and consequent G1 phase cells 
DSB repair kinetic in G2 phase after depletion of Rad52, BRCA2 and Polθ in various combinations is 
explained in section 4.8.1. In the consequent G1 phase cells (10 and 12 h post IR), it appears that the 
number of DSBs (yH2AX foci) in siCtrl-treated cells were divided almost equally in the daughter cells. 
Like G2 phase cells, depletion of Rad52 did not affect the DSB repair in the G1 phase cells. The repair 
defect observed in G2 phase cells (8 h post IR) after depletion of BRCA2 was also detectable in the G1 
phase cells (10 h post IR). However, as time progressed, the DSBs were repaired and no repair defect 
was detected for BRCA2-depleted situation at 12 h post IR as the number of residual yH2AX foci was 
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similar to control cells. This data suggests that, presence of Rad52 in BRCA2-depleted cells prevents 
the repair of DSBs in G2 phase by erroneous TMEJ pathway and postpones the repair process to the 
consequent G1 phase, where DSBs can be repaired either by c-NHEJ or by resection-dependent c-NHEJ 
pathway. The huge additive repair defect observed in G2 phase cells (8 h post IR) due to the 
BRCA2+Polθ depleted situation was also observed in the consequent G1 phase cells. However, in G1 
phase cells, a relatively slow repair of DSBs for BRCA2+Polθ depleted condition was observed. 
Figure 4.19. yH2AX foci kinetics in G2 and G1 phase. The cells were treated with siCtrl, siRad52, siBRCA2 and siPolθ in various 
combinations. Prior to irradiation (2 Gy X-rays) EdU-BrdU double labeling was performed and only EdU positive G2 and G1 phase cells 
were analyzed. The cells were stained with anti-yH2AX antibodies and DAPI. Samples were scanned using Metafer software. For each 
individual experiment ≥ 40 cells were analyzed. The foci numbers from unirradiated (0 Gy) samples were subtracted. The error bars 
represent the SEM of the mean values of three experiments. The siRNA efficiency was controlled by Western blot (shown in figure 
4.15). 
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5. Discussion
5.1. Homologous Recombination and Rad52 
Homologous Recombination is considered as one of the important biological mechanisms because of its 
active role in maintaining genomic stability and also because of its necessity for the faithful 
segregation of chromosomes during meiosis (Hanamshet, Mazina, & Mazin, 2016). HR constitutes a 
key repair pathway dedicated to faithfully repair complex DNA damages and is active mainly in the 
late S and G2 phases of the cell cycle when a sister chromatid is available as a template to repair DSBs 
(Heyer et al., 2010). In S. Cerevisiae, Rad52 is the key HR player as its inactivation is lethal for cells, 
whereas, in mammalian cells, loss of Rad52 exhibits normal DNA repair and HR phenotype. 
Nevertheless, increasing evidences from in vitro studies suggest that, in mammalian cells Rad52 might 
be involved in HR by mediating the formation of D-loops or by capturing the second end of a resected 
DSB (Kumar & Gupta, 2004; McIlwraith & West, 2008). As these functions (D-loop formation and 
second end capture) represent the late steps of HR, in this study also it was observed that the Rad52-
GFP foci number in G2 phase HeLa cells showed a slow increase and reached its maximum at late time 
point (7 h) post exposure to 2 Gy X-rays (figure 1 a) suggesting a function for Rad52 in late steps of 
HR. On the other hand, the foci kinetic observed for Rad51 was totally opposite to Rad52-GFP foci 
kinetic with Rad51 foci number reaching their maximum at an early time point (2 h) suggesting an 
early Rad51 response to IR-induced DNA damage (figure 4.1.a). This finding is in line with earlier 
published data by Wray et al. (2008) where an early Rad51 response and a late Rad52 response to IR-
induced DNA damage has been shown (Manuscript & Stress, 2009). However, in the above-mentioned 
publication, the authors conclude that Rad51 and Rad52 might be mediating different sub-pathways 
(DSBR/GC and SDSA, respectively) of HR. 
The involvement of Rad52 in HR in mammalian cells was further investigated. HR was abrogated by 
inhibiting resection and the expression of Rad52-GFP foci in G2 phase cells was analyzed. Resection, 
the initial step of HR, involves the nucleolytic degradation of 5' DNA end and gives rise to a 3'-ssDNA 
overhang. This process is known to be initiated by the MRN complex and CtIP together. Mre11, a 
component of the MRN complex, possesses endo- as well as exo-nuclease activity and its exo-nuclease 
activity has been shown to commit the repair of DSBs to HR. Therefore, upon inhibition of the exo-
nuclease activity of Mre11, no repair defect is observed in G2 phase as the cells still have the possibility 
to switch to c-NHEJ repair pathway (Shibata et al., 2014). Human CtIP is known to physically and 
functionally interact with MRN complex to mediate resection in mammalian G2 phase cells (Sartori et 
al., 2007). To impair resection, the cells were treated with Mirin, which inhibits the Mre11 
exonuclease activity, and siCtIP to deplete CtIP. Significantly lower numbers of Rad51 foci were 
detected after inhibition of resection compared to control cells, indicating an abrogated HR process 
(figure 4.2.a). Importantly, the involvement of Rad52 in HR was confirmed by observing that 
inhibition of resection resulted in significantly reduced Rad52-GFP foci in G2 phase HeLa cells (figure 
4.2 b). 
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Furthermore, HR was abrogated at a later step by depleting Rad54 and Rad52-GFP foci in G2 phase 
cells were analyzed. When Rad54 is depleted, Rad51 cannot be removed from the chromatin and the 
G2 phase cells are stuck with HR-intermediate structures, such as D-loops. In agreement with this 
notion, after depletion of Rad54, significantly increased Rad51 foci numbers were observed in G2 
phase cells at 7 h post irradiation (figure 4.3.a). Interestingly, under the same conditions (siRad54, 2 
Gy, 7 h), the number of Rad52-GFP foci significantly increased as well (figure 4.3.b). Previous work 
done in our laboratory has shown that Rad52-GFP foci are not only present in G2 phase, but also 
persist in the next M phase where they colocalize with Mus81 foci. Mus81 is a HR nuclease, which 
performs processing of HR-intermediate structures (D-loops, Holliday junctions) to finalize HR events. 
Therefore, it was hypothesized that Rad52 might play a role in keeping the HR-intermediate structures 
(D-loops, Holliday junctions) intact while the cell traverses from G2 to M phase. The significantly 
increased number of Rad52_GFP foci detected in the absence of Rad54 (figure 4.3 b) supports this 
hypothesis. Based on Rad52's activity to bind and wrap around ssDNA (Grimme et al., 2010), it is 
highly likely that when the cells get stuck with D-loops due to the absence of Rad54, Rad52 can bind 
to the ssDNA regions within the D-loops to keep these structures intact with the aim to finish repair in 
the consequent M or G1 phase. These results suggest that Rad52 is involved in the late steps of HR 
where it might be involved in mediating second end capture or in annealing complementary ssDNA 
strands post DNA repair synthesis. Additionally, in late G2 phase, Rad52 might also function to provide 
protection and keep the HR-intermediate structures intact while the cell traverses from G2 to M phase 
by binding to the ssDNA regions within the intermediate structures. 
5.2. Rad52 and BRCA2 
To understand the importance of Rad52 in BRCA2 proficient and deficient mammalian cells, both 
proteins were depleted either alone or in combination and the impact on cell growth was investigated. 
Additionally, Rad51 was also depleted (with or without Rad52) to understand if the association 
between Rad52 and Rad51 has any impact on cell growth. Cell proliferation experiments performed in 
this study showed that the absence of Rad52 had no impact on cell growth (figure 4.4.a and b). Given 
an important role for Rad51 during HR and in stabilizing stalled replication forks, its inactivation 
diminished cell growth, whereas, co-depletion of both Rad52 and Rad51 did not show any additive 
effect (figure 4 a and b). Like Rad51, inactivation of BRCA2 alone also resulted in diminished cell 
growth (figure 4 c and d). Interestingly, co-depletion of BRCA2 and Rad52 resulted in an additive 
negative impact and severely hindered cell proliferation (figure 4 c and d). These results are in line 
with the data published by Feng et al. (2011) and indicate that in the absence of BRCA2, Rad52 
becomes indispensable. However, it is still unclear if Rad52 can compensate for the loss of BRCA2 in 
loading Rad51 in G2 phase cells. Thus, the exact function of Rad52 in the absence of BRCA2 is not yet 
clearly understood. 
To address the aforementioned question, Rad52 and BRCA2 were depleted either alone or together 
and Rad51 foci were quantified in G2 phase cells. During HR in mammalian cells, BRCA2 interacts 
with Rad51 through its 8 BRC (Breast Cancer) repeats (Chatterjee et al., 2016) and actively loads 
Rad51 on the resected 3'-ssDNA. It has been shown that in Capan-1 cells, which do not express 
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functional BRCA2, very little Rad51 foci are formed in response to IR (Feng et al., 2011). In line with 
these observations, depletion of BRCA2 resulted in significantly low numbers of Rad51 foci in G2 
phase cells (figure 4.5.a), suggesting that Rad52 cannot compensate for the absence of BRCA2 in 
loading Rad51. Moreover, co-depletion of BRCA2 and Rad52 did not display any additive effect (figure 
4.5.a) indicating that the observed decrease in Rad51 foci number is a result of absence of BRCA2, and 
not Rad52. On the other hand, depletion of Rad52 alone had no impact on the formation of Rad51 foci 
and they were readily detected in G2 phase cells (figure 4.5.a). Also, there was hardly any co-
localization observed between IR-induced Rad52-GFP and Rad51 foci (figure 4.5.b and c). Although 
human Rad52 contains a Rad51-interacting domain (amino acids 291 – 330), Rad51 foci are readily 
formed in the absence of Rad52. The interaction between human Rad52 and Rad51 is thought to 
modulate Rad51's catalytic activities such as homologous pairing and strand exchange. Further on, the 
Rad51-interacting domain of human Rad52 shows no homology with yeast Rad52 indicating that the 
interaction between Rad52 and Rad51 is species-specific (Shen et al., 1996). Taken together these 
results suggest that during HR in mammalian G2 phase cells, Rad52 is not involved in the loading of 
Rad51 and cannot compensate for the loss of BRCA2. However, Rad52 might interact with Rad51 to 
modulate its catalytic activity rather than mediating active loading of Rad51 filaments on resected 3'-
ssDNA. Due to the synthetic lethality observed upon co-depletion of BRCA2 and Rad52, Rad52's 
function to mediate an alternative repair pathway was further investigated. 
5.3. Interplay of Rad52 and BRCA2 
HR is an error-free and a highly conserved mechanism for the repair of DNA DSBs. Moreover, HR plays 
an important role in restoring replication forks that have stalled or encountered a lesion and thus 
ensures a successful navigation through S phase. As such, HR is an essential biological mechanism 
required to maintain genome integrity and its dysfunction leads to diseases, cancer in particular 
(Negrini, Gorgoulis, & Halazonetis, 2010). One of the key factors of HR is BRCA2 and its importance is 
underlined by the fact that, individuals with BRCA2-mutations exhibit genomic instability and are 
predisposed to breast, ovarian and other cancers (Simon A. Gayther, Jonathan Mangion, 1997; 
Wooster et al., 1995). BRCA2-deficient cells are hypersensitive to genotoxic agents and replication 
stress (Heyer et al., 2010). Moreover, BRCA2 has been implicated in protecting perturbed replication 
forks against nucleolytic degradation (Schlacher et al., 2011). 
Consolidating the defined functions for BRCA2, in this study it was observed that depletion of BRCA2 
resulted in significantly decreased Rad51 foci numbers indicating inefficient Rad51 filament formation 
on the resected 3'-ssDNA (figure 4.6.a). As a consequence, a repair defect was observed in G2 phase 
cells displayed by high amounts of yH2AX foci compared to control cells (figure 4.6.b). Interestingly, in 
comparison to control cells, significantly increased numbers of Rad52-GFP foci were observed in 
BRCA2 depleted samples (figure 4.6.c). Moreover, at 2 h post irradiation, in BRCA2 depleted samples 
the average number of Rad52-GFP foci was very similar to the number of Rad51 foci in control 
samples (figure 4.6.a and c).These results suggest that, when HR is impaired, Rad52 binds to almost 
all the resected DSBs which were supposed to undergo repair by HR. Previous studies showed that 
human Rad52 can interact with and bind to RPA. Thus, in the absence of BRCA2, Rad52 and RPA 
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might form a complex on the resected DNA breaks. However, depletion of both BRCA2 and Rad52 did 
not result in an additive repair defect (figure 4.7), suggesting that both proteins are involved in the 
same HR pathway. This suggests that, increased Rad52-GFP foci numbers in a BRCA2-deficient 
background do not imply activation of a Rad52-mediated alternative repair pathway. Instead, 
depletion of BRCA2 and Rad52 together resulted in the rescue of the BRCA2 repair defect (figure 4.7). 
This rescue of the BRCA2 repair defect by additionally depleting Rad52 was observed not only for 
tumor cells (HeLa, figure 4.7), but also for human fibroblast cell lines (figure 4.8.a and b). Moreover, 
in addition to G2 phase, rescue of the BRCA2 repair defect by depleting Rad52 was also observed in S 
phase where HR is most active (figure 4.8 and 4.9.c and d). Like G2 phase, depletion of Rad52 in 
BRCA2-proficient cells did not induce any DSB repair defect in S phase (figure 4.9.a and b). Recently, 
Sotiriou et al. (2016) showed that, in S phase, Rad52 promotes BIR repair pathway and facilitates 
restart of collapsed replication forks (Sotiriou et al., 2016).  Additionally, they showed that, at 24 h 
after treatment with hydroxyurea (HU), yH2AX phosphorylation levels increased much strongly in cells 
depleted for Rad52. In this study, however, no repair defect was observed in S phase after depleting 
Rad52. 
Additionally, by scoring the number of unrepaired chromatid breaks in G2 phase (figure 4.13.a and c), 
the rescue of the BRCA2 repair defect after depleting Rad52 was further verified. In context of HR, 
these results suggest that in BRCA2-deficient cells, rather than mediating an alternative repair 
pathway, Rad52 accumulates on resected DSBs and prevents other, perhaps erroneous, repair 
pathways from acting upon the resected DNA breaks. Importantly, depletion of Rad52 in BRCA2-
deficient cells results in the repair of DSBs by a pathway which acts independently of both BRCA2 and 
Rad52. Hence, this repair pathway was characterized next. 
5.4. Contribution and fidelity of theta-mediated end joining repair pathway 
5.4.1. Contribution of TMEJ 
As mentioned in section 5.3, depletion of Rad52 in BRCA2-deficient cells resulted in the repair of DSBs 
by a pathway which acts independently of both BRCA2 and Rad52. As the absence of BRCA2 or Rad52 
does not hinder the process of end resection and given that TMEJ and HR share the initial step of end 
resection, the contribution of TMEJ in BRCA2 and Rad52 deficient cells to repair DSBs was further 
investigated. By scoring the number of yH2AX foci in G2 phase, it was observed that in BRCA2 
deficient cells, depletion of Rad52 resulted in an efficient repair of DSBs and the BRCA2 repair defect 
was rescued. Importantly, when factors of TMEJ repair pathway (PARP or Polθ) were additionally 
inactivated along with Rad52, no rescue of the BRCA2 repair defect was observed, displayed by 
substantially higher amounts of yH2AX foci compared to wild-type cells (figure 4.10.c and d). 
Furthermore, similar result was observed upon scoring the number of unrepaired chromatid breaks in 
G2 phase (figure 4.14.c). These results indicate that, in the absence of BRCA2 and Rad52, the resected 
DSBs are repaired by a PARP and Polθ-dependent pathway. Thus, due to the loss of BRCA2 and Rad52, 
the repair of the resected DSBs is channeled to TMEJ. 
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In support of the finding that Polθ-dependent TMEJ repair pathway rescues the BRCA2 repair defect, 
additional work from the group of Prof. Löbrich has shown that c-NHEJ repair pathway is not 
responsible for the rescue process. Experiments performed with c-NHEJ-deficient cell line have shown 
that the rescue of the BRCA2 repair defect takes place independent of c-NHEJ pathway (figure 5.1.a 
and b). By scoring yH2AX foci a repair defect was observed in siCtrl-treated XLF-deficient hTert cells in 
comparison to wt 82-6 hTert cells at 8 h post IR (figure 5.1.a).  By depleting BRCA2 in XLF-deficient 
cells, an additive repair defect was observed and, importantly, the additive repair defect was rescued 
when Rad52 was additionally depleted (figure 5.1.a). Further on, in HeLa cells, rescue of the BRCA2 
repair defect was still observed when Ligase IV, a c-NHEJ factor, was depleted (figure 5.1.b). 
Therefore, these results further validate and support the notion that the rescue of the HR defect in G2 
phase is a c-NHEJ-independent and TMEJ-dependent process. 
Figure 5.1. Rescue of the BRCA2 repair defect in c-NHEJ-independent process. 30 min prior to irradiation (2 Gy X-rays) HeLa cells 
were treated with EdU to label and exclude S phase cells from analysis. The cells were stained with anti-yH2AX antibodies and DAPI. 
Samples were scanned using Metafer software. For each individual experiment ≥ 40 cells were analyzed. (A) yH2AX foci quantification 
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in G2 phase wt 82-6 and XLF-deficient hTert cell lines. Before irradiation, the cells were treated with siRad52 and/or siBRCA2. 
Additionally, the cells were treated with a control siRNA. (B) yH2AX foci quantification in G2 phase HeLa cells. Before irradiation, the 
cells were treated with siBRCA2 or siBRCA2+siRad52+siLigIV.The foci numbers from unirradiated (0 Gy) samples were subtracted. 
The error bars represent the SEM of the mean values of three experiments. Experiments were performed by Marta Llorens Agost. 
It has been demonstrated that TMEJ is limited by RPA bound to ssDNA. Resection of DSB ends reveals 
microhomologies present internal to the break ends, however, these microhomologies are not 
accessible to the TMEJ machinery due to the presence of RPA. Only after the removal of RPA are these 
microhomologies exposed and made available to the TMEJ machinery to continue repair (Deng et al., 
2014). 
To further consolidate the contribution of TMEJ to repair DSBs in the absence of BRCA2 and Rad52, 
pRPA foci were quantified in G2 phase fibroblast cells. In comparison to WT 82-6 cells, BRCA2-
deficient HSC-62 cells showed higher amounts of pRPA foci at 2 and 6 h post IR, representing a BRCA2 
defect (figure 4.11.a). Interestingly, a significant decrease in the pRPA foci numbers was observed 
upon depleting Rad52 in HSC-62 cells (figure 4.11.a), indicating that less RPA is bound to ssDNA, 
thereby making the microhomologies available to the TMEJ machinery. Furthermore, in HSC-62 cells, 
upon additional depletion of Polθ together with Rad52, no decrease in pRPA foci numbers was 
observed (figure 4.11.b). This suggests that, in the absence of Polθ, RPA cannot be removed from the 
3'-ssDNA overhang and TMEJ cannot be activated. These results, however, do not clearly explain if 
Polθ is actively involved in the removal of RPA from ssDNA to initiate repair by TMEJ pathway, or if 
RPA is removed by some other factors to activate repair by TMEJ. Nevertheless, these results suggest 
that, in cells deficient for BRCA2 and Rad52, less RPA is bound to the 3'-ssDNA overhang which 
facilitates repair by TMEJ. 
5.4.2. Fidelity of TMEJ 
TMEJ is a mutagenic repair pathway with potentially harmful consequences on genome integrity. It 
has been shown that TMEJ can result in the joining of different chromosomes, thereby generating 
chromosomal translocations and mutagenic rearrangements. In c-NHEJ deficient cells, increased 
amounts of chromosomal translocations have been observed, suggesting a role for TMEJ in giving rise 
to these translocation events. Furthermore, it recently became evident that TMEJ is triggered upon 
telomere de-protection to promote Polθ-dependent formation of chromosome end-to-end fusions 
(Ceccaldi,  Rondinelli ,  et al. ,  2015; Mateos -Gomez et al. ,  2015). 
In section 5.4.1 it was established that DSB repair in BRCA2 and Rad52-deficient cells is PARP and 
Polθ dependent. Next, the fidelity of the TMEJ repair pathway was examined. In G2 phase, after 
depletion of Rad52 in BRCA2-deficient cells, a substantial increase in the number of chromosomal 
fusions was observed (figure 4.13.b). The amount of chromosomal fusions was even higher when the 
cells were additionally treated with CPT to induce damages in S phase where HR is most active (figure 
4.13.d). These results are consistent with the data published by Feng et al. (2011) where they showed 
that the absence of both BRCA2 and Rad52 results in extensive chromatid-type aberrations (Feng et 
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al., 2011). The high amounts of chromosomal fusions observed can be highly detrimental for cells and, 
thereby, might explain the reason why loss of BRCA2 and Rad52 is lethal for cells. Thus, presence of 
Rad52 in BRCA2 deficient cells prevents repair by the mutagenic TMEJ pathway and suppresses 
chromosomal aberrations and thus plays an important role in the survival of these cells. Consistent 
with this function of Rad52, a similar function to suppress TMEJ has also been shown for other HR 
factors – such as, BRCA2, BRCA1 and RPA. By using a sensitive HPRT assay to monitor DSB mis-repair, 
it was found that depletion of these HR proteins results in distinct mutational signatures associated 
with deletions and annealing of short regions of microhomologies. Furthermore, it was shown that 
these mutational signatures were PARP and Polθ-dependent and thus indicative of TMEJ (Ahrabi et al., 
2016). 
5.5. Distinct impacts of TMEJ in human fibroblast vs cancer cell lines 
In this study, the impact of TMEJ on DSB repair and chromosomal aberrations and the function of 
Rad52 to suppress these mechanisms in human cancer cell lines was investigated. By scoring yH2AX 
foci in G2 phase HeLa cells (cell line derived from epithelial cervical cancer), it was observed that 
BRCA2-depletion resulted in a repair defect, while additional depletion of Rad52 rescued the BRCA2 
repair defect (figure 4.15). Importantly, an increased number of chromosomal fusions were observed 
under these conditions (figure 4.16.b). Hence, like fibroblast cells, Rad52's function to prevent 
formation of chromosomal fusions in HeLa cells was consolidated. However, depletion of Polθ in HeLa 
cells resulted in different consequences as compared to fibroblast cells and these differences are 
discussed in the following paragraph. 
As mentioned earlier, in fibroblast cell lines, Polθ-dependent TMEJ repair pathway was activated only 
in the absence of BRCA2 and Rad52. Further on, no repair defect was observed in G2 phase after Polθ 
depletion in WT 82-6 or BRCA2-deficient HSC-62 fibroblast cells (figures 4.10.b and d). To our 
surprise, unlike fibroblast cell lines, single depletion of Polθ resulted in a repair defect in G2 phase 
HeLa cells at 8 h post IR (figure 4.15). Furthermore, a huge additive repair defect was observed upon 
co-depletion of BRCA2 and Polθ in HeLa cells, showing that these two factors are not epistatic (figure 
4.15). These results indicate that in HeLa cells, BRCA2-dependent HR and Polθ-dependent TMEJ are 
active simultaneously. This implies that, in comparison to fibroblast cell lines, cancer cells deploy both 
resection-dependent pathways (HR and TMEJ) to repair DSBs. Although TMEJ is active alongside HR 
in HeLa cells, a repair defect is observed by depleting BRCA2 which is rescued upon depletion of 
Rad52. This observation raises the question, what makes a sub-class of HR-committed breaks so special 
that, in case of impaired HR, Rad52 prevents the repair of these DSBs by TMEJ. 
As discussed earlier, HR and TMEJ share the initial step of DSB end resection and diverge post 
resection (Truong et al., 2013). Therefore, it is likely that end resection dictates repair pathway choice. 
It has been shown that the first phase of resection, called end clipping, is carried out by the structure-
specific nucleases Mre11 and CtIP and relatively small number of base pairs are processed (i.e., 20 bp 
in mammalian cells or 100-300 bp in yeast). This makes the DNA ends available for joining by TMEJ 
(Huertas & Jackson, 2009; Truong et al., 2013). In the second phase of end resection, called extensive 
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resection, helicases and exonucleases (DNA2, BLM, WRN and EXO1) generate long stretches of ssDNA, 
thereby committing the cells to HR (Sturzenegger et al., 2014; Symington & Gautier, 2011). ‘It is 
possible that repair of extensively resected DSBs by TMEJ can result in large deletions and other 
chromosomal aberrations. Therefore, it is likely that in case of impaired HR in HeLa cells, Rad52 binds 
to a sub-class of DSBs which underwent extensive resection and generated long stretches of 3'-ssDNA 
overhangs. As Rad52 can interact with and bind to RPA, it is possible that Rad52 and RPA form a 
complex on these long stretches of 3'-ssDNA overhangs. This Rad52-RPA complex prevents repair by 
TMEJ at these HR-committed breaks and consequently avoids formation of chromosomal fusions, 
which can be lethal for cells. A hypothesized model, explaining the function of Rad52 in G2 phase 
HeLa cells, is shown in figure 5.2. 
Figure 5.2. Speculative model for the function of Rad52. Depending on the extent of resection, in G2 phase mammalian cancer cells, 
extensively resected DSBs undergo repair by HR, whereas, shortly resected DSBs can be repaired by TMEJ. In case of impaired HR, 
Rad52 binds to the long stretches of 3'-ssDNA overhangs and prevent their repair by the erroneous TMEJ pathway. Activation of TMEJ 
pathway in the absence of BRCA2 and Rad52 results in the formation of chromosomal fusions. Thus, by inhibiting TMEJ and preventing 
the formation of chromosomal fusions, Rad52 maintains genomic stability in BRCA2-deficient cells. 
By using EdU-BrdU double labeling, damage-induced G2 phase cells were analyzed in the consequent 
G1 phase and DSB repair kinetic was performed.  It was observed that the repair defect, incurred in G2 
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phase (8 h post IR) due to the absence of BRCA2, was absent in the consequent G1 phase, indicating 
ongoing repair in G1 phase (figure 4.19). This data suggests that, in BRCA2 deficient G2 phase cells, 
Rad52 prevents the repair by TMEJ (an erroneous pathway) and postpones the repair to the next G1 
phase. A huge repair defect was still detectable in G1 phase for BRCA2 and Polθ depleted situation and 
the DSBs were repaired relatively slowly. However, more control experiments are needed to be 
performed to confirm and validate the results obtained from G1 phase cells. 
5.6. Chromosomal analysis in HeLa cells 
Genomic instability refers to an increased tendency of alterations in the genome during the life cycle of 
cells. It is one of the hallmarks of cancer and is present in all stages of cancer, from initiation to 
advanced cancer (Nowell, 1950). Recently it became evident that the HR-deficient tumors are 
dependent on Polθ-mediated repair and, moreover, a synthetically lethal relationship between HR and 
Polθ-mediated repair has been revealed (Ceccaldi, Liu, et al., 2015). Additionally, it has been shown 
that HR-deficient tumor cells (U2OS) expressing high levels of Polθ, harbor more somatic point 
mutations compared to tumors with lower Polθ levels (Alexandrov et al., 2013). These results suggest 
that Polθ contributes to a certain extent in maintaining genomic instability in HR-deficient tumors. 
Chromosomal analysis in G2 phase HeLa cells showed that the rescue of the BRCA2 repair defect by 
depleting Rad52 occurred at the cost of chromosomal fusions (figure 4.16.a and b). Thus, Rad52's 
function to prevent chromosomal fusions was observed in HeLa cells. Further on, consistent with the 
yH2AX foci data, depletion of Polθ or BRCA2 showed higher numbers of unrepaired chromatid breaks 
compared to the siCtrl-treated cells (figure 4.16.a). However, no substantial increase in chromosomal 
fusions was observed after depleting Polθ or BRCA2 (figure 4.16.b). Importantly, co-depletion of 
BRCA2 and Polθ resulted in significantly higher number of chromatid breaks and fusions (figure 4.16.a 
and b). This observation confirms the earlier finding that HR and TMEJ both are simultaneously active 
in the G2 phase HeLa cells. In line with this notion, increasing evidence suggest that TMEJ is an 
important repair pathway in cancer cells. It has been shown that HR-deficient tumors rely heavily on 
Polθ-mediated repair for their survival. Additionally, it was shown that inactivation of Polθ in Fancd2-
deficient (an HR gene) cells increased cell killing (Ceccaldi, Liu, et al., 2015). Furthermore, a 
substantial increase in chromosomal aberrations was observed after inactivation of Polθ in BRCA2 
mutant cells (Mateos-Gomez et al., 2015). The increased numbers of chromosomal fusions observed in 
BRCA2+Polθ depleted cells suggest that, in the absence of HR and TMEJ, c-NHEJ can mis-rejoin DSBs 
and induce chromosomal fusions. Consistent with this finding Mateos-Gomez et al. (2015) showed 
that, inhibition of Polθ in BRCA-mutant cells leads to increased chromosomal aberrancies, especially 
radial chromosomal structures which are characteristic of Lig4-mediated processing via the c-NHEJ 
pathway (Mateos-Gomez et al., 2015). 
Taken together, the results obtained in this study provide a novel insight to understand the role of 
Rad52 in the absence of BRCA2 in mammalian cells. Rad52 plays an important role in the survival of 
BRCA2-mutant cells by avoiding chromosomal fusions. This makes Rad52 a potential drug target to 
specifically kill BRCA2-mutant tumors without any adverse effects on healthy cells and tissue. As loss 
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of Polθ in BRCA2-deficient cells is also detrimental, inactivation of both Rad52 and Polθ in BRCA2-
mutant tumors might provide an alternative strategy to treat cancer. 
5.7. Outlook 
Rad52 is an evolutionary conserved protein. In S. Cerevisiae, Rad52 is the key player of HR-mediated 
DNA repair and other recombination events. Importantly, absence of Rad52 in S. Cerevisiae is lethal. 
On the contrary, in mammalian cells, inactivation of Rad52 has no significant effect on HR or DNA 
repair in general. Recent studies have shown that, in BRCA-deficient mammalian cells, Rad52 is an 
indispensable factor and its presence renders viability to the cells. Furthermore, loss of Rad52 in 
BRCA-deficient cells is synthetically lethal. However, the exact functions of Rad52 which render 
viability to BRCA-deficient cells are yet unknown. 
In this study, it was shown that in HeLa cells, Rad52-GFP foci peak at late times (8 h) in G2 phase 
after exposure to IR and persist in the consequent M phase, indicating a function for Rad52 at the late 
steps of HR. Importantly, it was shown for the first time that in G2 phase of BRCA2-depleted HeLa 
cells, significantly increased numbers of Rad52-GFP foci are present at early time point (2 h) after IR, 
suggesting that Rad52 binds to the resected break ends. Furthermore, it was observed that depletion of 
Rad52 in BRCA2-deficient cells rescued the BRCA2 repair defect in a TMEJ-dependent manner. 
Moreover, the rescue process mediated by TMEJ-repair pathway gave rise to chromosomal fusions, 
thereby compromising genomic stability. Thus, it was shown that, in G2 phase, Rad52 prevents the 
formation of chromosomal fusions and helps to maintain genomic stability. 
In response to IR, unlike other HR factors (Rad51 and Rad54), Rad52-GFP foci are present in M phase. 
Moreover, in M phase, Mus81 foci are present along with Rad52-GFP foci. This data indicates that 
Rad52 might be mediating the Mus81-Eme1 complex-dependent resolution pathway to process the 
DHJs. In vitro experiments have shown that Rad52 captures the second-end of DSBs and, thus, helps in 
the formation of HR-intermediate structures (DHJs) (Nimonkar, Sica, & Kowalczykowski, 2009). 
Therefore, analysis of M phase cells will be helpful in understanding if Rad52 mediates formation or 
processing of DHJs. Furthermore, sister chromatid exchange analysis can provide additional 
information regarding the function of Rad52 in the formation of cross-over products. 
By detecting the formation of EdU foci in M phase, Bhowmick et al. (2016) showed that mitotic DNA 
synthesis (MiDAS) takes place in a Rad52-dependent manner. Importantly, this function of Rad52 is 
independent of Rad51 and BRCA2. Furthermore, they showed that no DNA synthesis occurs in M 
phase in the absence of Rad52 and this gives rise to increased numbers of 53BP1 nuclear bodies in the 
consequent G1 phase (Bhowmick, Minocherhomji, & Hickson, 2016). In this publication, however, 
DNA damage originates from S phase at common fragile site (CFS) loci which, upon inducing 
replication stress, appear as DAPI-negative gaps on metaphase chromosomes. Therefore, it is highly 
interesting to investigate if Rad52 can promote repair of DSBs induced in G2 phase by mediating 
MiDAS, especially in HR-defective cells. This information is important and can help to understand how 
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HR-defective cancer cells repair endogenous DSBs and maintain their genomic stability when an error-
free repair pathway in unavailable. 
In addition to M phase, the function of Rad52 in S phase to repair one-ended DSBs is not yet fully 
understood. Recently, Sotiriou et al. (2016) showed that, in S phase, Rad52 mediates the strand 
invasion step to promote break-induced replication repair (BIR) and, thus, facilitates restart and repair 
of collapsed replication forks in cancer cells (Sotiriou et al., 2016). However, like Rad51, a 
recombinase activity for Rad52 has not yet been described. Biochemical analysis of Rad52 protein can 
provide important insight to understand Rad52's function of strand invasion. Furthermore, it would be 
interesting to understand if, in HR-defective cells, Rad52 can promote strand invasion in G2 phase 
and, thereby, facilitate MiDAS to repair IR-induced DSBs. 
Recently, a direct role of RNA in the repair of DSBs has been revealed (Keskin et al., 2014). 
Interestingly, Mazina et al. (2017) showed that, in eukaryotes, inverse strand exchange between 
homologous dsDNA and RNA is a distinct activity of Rad52 (Mazina et al., 2017). In addition, recent 
investigations from the group of Prof. Löbrich have revealed that, in response to IR, RNA-DNA hybrids 
are formed that are involved in DSB repair by mediating resection and consequent formation of pRPA 
foci in G1 phase mouse embryonic stem cells (mESCs) (Dissertation, Amir Mofidi, 2017). Therefore, it 
would be highly interesting to understand if Rad52 is involved in the formation of RNA-DNA hybrids 
and, thus, plays a role in RNA-mediated DSB repair. This information will also be helpful to 
understand the repair of DSBs in G1 phase where limited end resection of DSBs has been shown (Biehs 
et al., 2017). 
In this study, it was shown that the absence of Rad52 in BRCA2-deficient cells leads to the formation 
of chromosomal fusions and severely hinders cell growth. Consistent with these findings, other studies 
have shown that inactivation of Rad52 in BRCA2-deficient cells induces chromosomal aberrations and 
is synthetically lethal (Feng et al., 2011). In recent years, the synthetic lethal relationship between 
Rad52 and BRCA2 has been exploited to selectively kill BRCA-deficient cancer cells (Chandramouly et 
al., 2015; Huang et al., 2016). In context to cancer therapy, screening of inhibitors to disrupt the 
activity of Rad52 is highly important as this strategy holds a lot of potential to specifically treat BRCA-
deficient cancers. 
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